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ABSTRACT OF THE DISSERTATION
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by
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Professor William Darrow, Major Professor
Human papillomavirus (HPV) is a preventable infection responsible for anogenital and
oropharyngeal cancers, as well as genital warts. Two safe and effective vaccines are
recommended for adolescents and young adults to protect against HPV infection. Both are
severely underutilized. Sexual and ethnic minorities are disproportionately affected by
HPV infection and its sequelae. The goals of this study were to (1) assess baseline
differences in HPV-related awareness, knowledge, and attitudes between men and women,
and (2) evaluate the differential efficacy of a brief, educational HPV intervention among
ethnically and sexually diverse college students. Students attending undergraduate courses
from 2015 to 2017 participated in a brief, tailored, classroom intervention designed to
improve HPV-related awareness, knowledge, and attitudes. These outcomes were assessed
immediately before and following an evidence-based educational presentation about HPV
risks, outcomes, treatments, and prevention. At baseline, 84% of participants (N=386) had
heard of HPV; 28% of men and 55% of women reported receiving ≥1 dose of HPV vaccine.
Vaccinated women were seven times more likely to report favorable attitudes than

vii

unvaccinated women (RR=7.1, CI[3.3-15.5]). Hispanic participants had more positive
attitudes toward HPV vaccination (62% vs. 44%; P=0.009) and were more willing to
become vaccinated (66% vs. 46%; p=0.02) than non-Hispanic participants at baseline. Gay
and bisexual men (92%) were more likely than heterosexual men (68%) to have heard of
HPV, to receive any doses of HPV vaccine (37% vs 19%), to view HPV vaccination
positively (58% vs 39%), and more willing to be vaccinated (86% vs 39%; P<0.05).
Following the intervention, participants’ HPV knowledge improved by 41%. Baseline
disparities between genders, ethnicities, and sexual orientations dissipated at post-test.
Participants rated the intervention components and overall experience positively (93-97%).
In summary, significant disparities exist in HPV-related awareness, knowledge, and
attitudes between students of different genders, ethnicities, and sexual orientations.
Tailored and targeted educational interventions can be a successful method for diminishing
these disparities, encouraging HPV vaccination, and relieving the burden of HPV and its
adverse outcomes.
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CHAPTER I
Introduction
Health promotion has been defined by the World Health Organization as “The
process of enabling people to increase control over, and to improve, their health. It moves
beyond a focus on individual behavior towards a wide range of social and environmental
interventions.”1 In the same vein, disease prevention specifically focuses on populationor individual-level prevention efforts aimed at reducing the incidence and burden of
diseases and their associated risk factors. Health promotion and disease prevention often
share goals, and both often utilize education and educational interventions as a means for
reaching specific goals.2
Historically, interventions to prevent sexually transmitted infections (STIs) were
not a priority among health promotion professionals. STI control was mainly the concern
of military and private physicians in the United States (U.S.), with early behavioral
efforts targeting high-risk groups, such as prostitutes and military personnel.3 Behavioral
approaches to prevention became secondary to the biomedical model in the early 1900s
with improvements in diagnostic techniques, discovery of antibiotics and treatment with
heavy metal compounds, and epidemiological methods.4 With the discovery of
autoimmune deficiency syndrome (AIDS) in the early 1980s, the biomedical model was
viewed as only a part of the solution; early detection and no cure offered little to prevent
transmission of the deadly disease.4 Modifications of sexual behavior was increasingly
acknowledged as not only a potential preventive tool for curtailing STIs, but essential for
the success of the biomedical interventions as patient and provider behaviors surrounding
screening, diagnosis, and treatment were scrutinized. 4
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In 1990, the Department of Health and Human Services released the report
“Healthy People 2000,” a strategy for significantly improving the health of the U.S.
through 300 specific health objectives spanning areas such as maternal and child health,
cancer, sexually transmitted infections (STIs), and vaccines.1 The legacy of “Healthy
People” has continued through the decades, with increasing emphasis on prevention, and
expansion of disparity groups. Attention has increasingly focused on preventable cancers,
such as cervical cancer caused mainly by human papillomavirus (HPV). 5
High priority research to advance prevention of HPV-associated cancers includes
effective communications about HPV and the safe and effective HPV vaccines to
accelerate uptake, and development of cost-effective research to do so efficiently in atrisk populations. Barriers to HPV vaccination include lack of knowledge, missed clinical
opportunities to vaccinate, limited access to healthcare, and cost concerns.5 Effective
interventions often employ a specific theoretical model, evidence-based information,
rigorous outcome evaluation, and multidimensional measurement (e.g. knowledge and
attitudes). Brief, simple educational interventions modeled after early HIV prevention
efforts have been shown to improve knowledge of HPV and HPV vaccination. 4
Purpose of the Study
The purpose of this study was to (1) assess the efficacy of a brief educational
intervention in improving HPV-related awareness, knowledge, and attitudes and (2)
determine if impact varies by gender, ethnicity, and sexual orientation in a purposive
sample of ethnically and sexually diverse 18-26-year-old Florida International University
(FIU) college students. The intervention group was composed of students registered in
the course WST 3641- “LGBT and Beyond: Non-Normative Sexualities in Global
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Perspective,” a course in which LGBTQ undergraduate students are known to be
overrepresented (~35% LGBTQ students).
Theoretical Foundations
To explain how gender, ethnicity, and sexual orientation are associated with
levels of knowledge and attitudes towards HPV, the Health Belief Model (HBM) in
conjunction with the Transtheoretical Model (TTM) guided the study design, intervention
content, and interpretation of results.
Figure 1.1. Model of Theoretical Foundations

HBM posits that beliefs and attitudes about a specific disease influence decisions
about prevention, particularly vaccination behavior.6 HBM has been successfully
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validated and used to guide many public health interventions aimed at behavior change
among various populations, and develop effective health messages within and without an
intervention framework.7
This study utilized the HBM constructs of perceived susceptibility, threat,
severity, cues to action, as well as perceived barriers and benefits framed within the brief
educational presentation aimed at preventing HPV infection and encouraging vaccination.
Constructs informed the manner of information presentation, and how to measure uptake
of the information by participants. Knowledge, the largest barrier related to HPV-related
behaviors, is an integral construct of this theoretical model, being a prerequisite for
making informed decisions about behavior change and vaccination. 8
This study also utilized TTM, a theory that integrates several constructs of
behavior change to assess or even predict readiness to engage in a new or healthier
behavior.9,10 Rather than a single decision-making event, TTM considers behavior change
as a process in which individuals progress through a series of stages (precontemplation,
contemplation, preparation, action, and maintenance) depending on their baseline
readiness to adopt or perform a health behavior. These constructs of TTM were used to
determine participants’ stage of change and associations related to each stage, and were
measured at baseline, prior to intervention exposure.
Study Setting: WST 3641 LGBT and Beyond: Non-Normative Sexualities in
Global Perspective
WST 3641 is a 3-credit course at Florida International University designed to
introduce students to the study of global non-normative sexualities and genders.
According to the course syllabus,11 students gain an interdisciplinary understanding of
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gender studies with historical, sociological, and geographical, underpinnings. Through
this course, students explore concepts related to lesbian, gay, bisexual and transgender
(LGBTQ)-identified individuals as well as those whose sexual and gender identities,
practices, and experiences fall outside such designation. In this sense, students learn to
understand how and when classifications, assumptions, concepts, and theories of
sexuality and gender prove inappropriate for other cultural contexts. Students examined
how modern non-normative sexualities and genders around the world exist at the
intersection of local and global processes.
Research Aims and Hypotheses
Three research questions were based on student knowledge and attitudes
regarding HPV and related topics, which were operationalized based on students’ survey
results, with intervention acceptability and efficacy determined quantitatively through a
post-intervention survey.
Research Question 1. In a sexually diverse sample of undergraduate students
what is the difference in knowledge about HPV and the HPV vaccines among students of
varying genders, ethnicities, and sexual orientations before and after implementation of a
brief educational intervention?
Research Question 2. How can HPV-related attitudes be characterized among
samples of undergraduate students of varying genders, ethnicities, and sexual orientations
before and after implementation of a brief intervention?
Research Question 3. How acceptable and efficacious is a brief educational
intervention in a university classroom setting to educate sexually diverse undergraduate
students about HPV and HPV vaccination?
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To answer these research questions, the following aims were developed, and the
associated hypotheses were tested. Chapters IV, V, and VI, each address one of these
aims.
Aim 1 (Chapter IV). To assess baseline differences in HPV-related awareness,
knowledge, and attitudes between genders.
H0:

There are no differences between genders in baseline awareness,
knowledge, or attitudes in HPV-related topics.

H1:

At baseline, there are statistically significant differences between men and
women in HPV-related awareness, knowledge, and attitudes.

Aim 2 (Chapter V). To evaluate the efficacy of a brief intervention in improving
HPV-related awareness, knowledge, and attitudes among ethnically diverse college
students.
H0:

There are no differences in intervention outcomes between Hispanic and
non-Hispanic participants.

H1:

There are statistically significant differences in intervention outcomes
between Hispanic and non-Hispanic participants.

Aim 3 (Chapter VI). To evaluate the efficacy of a brief intervention in improving
HPV-related awareness, knowledge, and attitudes among sexually diverse college
students.
H0:

There are no differences in intervention outcomes between LGBTQ and
heterosexually-identifying participants.

H1:

There are statistically significant differences in intervention outcomes
between LGBTQ and heterosexually-identifying participants.

6

Delimitations
Study participation was restricted to students at least 18 years old attending FIU.
Students attending college create a unique chance to access individuals who may have
missed opportunities to become vaccinated against HPV as minors, and are now of age to
make vaccination decisions of their own volition. Students chosen for this study included
those registered for the FIU courses WST 3641- “LGBT and Beyond: Non-Normative
sexualities in Global Perspective”, which allowed for a sample with a diverse blend of
ethnicities and sexual orientations, and IDS 3189: “International Nutrition, Public Health
and Economic Development”, which served as a comparison group.
Limitations
Since this study was performed in the unique urban setting of Miami-Dade
County, the results of this research may not be applicable to those attending other
universities, and living in other geographical areas. Non-probability purposive sampling
was used to include diverse sexual orientations; participants were not representative of all
students at Florida International University, or the south Florida area. Collection of selfreported data limited the ability for these data to be independently verified for bias.
Recall and social desirability biases may also have affected the responses of study
participants.
Assumptions
The underlying assumptions of this research are that the participants responded to
survey instruments accurately and truthfully, and that they had at least an 8th grade
English reading and comprehension level. Survey instruments were valid and reliable
based upon literature reviews and pilot testing.
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Importance of Study
Students attending college create a unique opportunity to access individuals who
may have missed opportunities to become vaccinated against HPV, and are now of age to
make vaccination decisions of their own. The south Florida region has particularly high
rates of infection, and low rates of vaccination.12 Ethnic minorities and LGBTQ
individuals are less likely to receive relevant vaccination recommendations from
healthcare providers, in addition to perceiving a lower threat of HPV.
To increase HPV vaccination uptake and close gaps in knowledge and health
behaviors among sexual and ethnic minority groups, knowledge and attitudes related to
HPV and HPV vaccination should be examined and addressed. The results of this study
will guide future interventions and policy to create culturally appropriate messages in
settings that maximize opportunities for change. This study also represents an opportunity
to contribute to multiple Healthy People 2020 goals related to LGBTQ health, and
vaccine uptake.13
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CHAPTER II
Review of the Literature
Human papillomavirus (HPV) infection is the most common STI globally.1 Highrisk subtypes of the virus are human carcinogens, responsible for cervical, genital, anal,
and oropharyngeal cancers. Low-risk subtypes are the cause of genital warts. Almost 80
million sexually active adults, one in four in the United States, are infected with HPV,
despite the preventable nature of the infection.1 Young adults age 15-24 account for
approximately half of all new infections every year.1,2 An estimated additional 14 million
will become newly infected each year if action is not taken to provide optimal prevention
options to those at highest risk.
Causation and Risk
In 1983, HPV was characterized as the biological factor causing cervical cancer,
genital warts, and even penile cancer by a team of researchers led by Harald zur
Hausen.3,4 Primary research was aimed at determining the DNA sequences of the various
isolated strains of the virus for detection, determining that HPV-16 and -18 are the most
virulent strains, causing the majority of pre-cancerous cervical dysplasia and cervical
cancer itself. Zur Hausen was awarded the Nobel Prize for Medicine or Physiology in
2008; soon after discovery, this claim was confirmed in other laboratories.5
Once the cause of cervical cancer provided verification that it was indeed sexually
transmitted, researchers began to explore the various risk factors and exposures which
increase the chances of contracting the disease. As early as 1990, Moscicki et al. studied
sexually active female adolescents, finding those with an active HPV infection had
significantly more lifetime sexual partners than their uninfected counterparts, likely a
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result of exposure to multiple sources of infection.6 The authors note that the majority of
the participants who tested positive for oncogenic HPV strains had normal Papanicolaou
(Pap) test results, indicating the need for early preventative and detection measures prior
to allowing the disease to advance. It has been suggested that the majority of the HPV
infections among younger females are due to exposure through a new partner, and may
be a more short-lived, transient infection.7 A study in Denmark shares these sentiments,
adding that these transient infections are more often associated with the low-risk, nononcogenic HPV types.8
A few studies indicate that among older women, persistent and/or latent HPV
infections are more common, possibly leading to higher risk for cervical cancer
outcomes.8,9 Munoz et al. (1996) found that among middle-aged women in their 40s and
50s, having six or more lifetime sexual partners was associated with a fourfold increase
in risk.10 In addition, there was a statistically significant positive association between
HPV infection and low socioeconomic status as well as previous C. trachomatis
(chlamydia) infection. Munoz et al. also found that infections were found among women
who were not recently sexually active, in accordance with previous findings that indicate
that HPV infections could be persistent in nature, creating a clinically significant
outcome long after acquisition.
Sexual behavior and characteristics of male sexual partners have been explored
among women in college (reported by the woman), and among married men. Burk et al.
(1996) found that age >20 years, Black or Hispanic ethnicity, currently not attending
college, and increased number of sexual partners among male partners was associated
with HPV positivity among the female partners.11 Related studies among Spanish-
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speaking populations confirmed that husbands of women diagnosed with cervical cancer
are indeed vectors of the HPV virus, and exposure to the virus is mediated by factors
such as extramarital sexual relationships and a large number of sexual partners. 10
HPV and HPV Vaccination
More than twenty years after the isolation of HV-16 and HPV-18, vaccinations
became licensed in the U.S. Safe and effective vaccines have been licensed to protect
against HPV since 2006, and have been proven to decrease HPV-related morbidity.12 The
quadrivalent HPV vaccine protects against the two main high-risk and the two main lowrisk HPV subtypes. The 9-valent HPV vaccine protects against these and an additional
five subtypes.12 The suggested age to routinely vaccinate is 8-11 years old, but the
recommendation is extended for women up to age 26 and men up to age 21 if they were
not vaccinated when younger. It is ideal for adolescents to be vaccinated prior to first
sexual contact. Those with compromised immune systems as well as gay or bisexual men
are also urged to receive the vaccination though age 26.13
Both vaccines operate on the same dosage and administration schedule. Each dose
consists of 0.5mL of virus-like particles (not live virus), which is injected intramuscularly
in two doses if given between 8-11 years old, three doses otherwise. The second dose is
administered between 4 and 8 weeks after the first, and the third is administered 12 weeks
after the second. Women who experience abnormal Pap test results are still encouraged to
become vaccinated to protect against infection by other HPV types.13
The U.S. Department of Health and Human Services calculates that
approximately 53,000 cases of cervical cancer can be prevented if 80% HPV vaccination
coverage can be achieved among eligible adolescents and young adults who remain a

12

priority population due to disproportionately high HPV incidence.14 The available HPV
vaccines are currently underutilized in the adolescent and young adult population for
which they are intended, generating a setting for preventable HPV-associated
malignancies and related mortality to rise.15 Despite advancements in screening, the state
of Florida has one of the highest cervical cancer incidence rates nationwide.16
The efficacy and safety of the vaccines has prompted countries other than the U.S.
to begin routine vaccination of their adolescents and young adults, with positive results.
In 2008, Scotland commenced a nation-wide HPV vaccination program in which all
adolescent females between 12 and 18 years of age were recommended to become
routinely vaccinated.17 Since 2008, the percentage of fully vaccinated girls has increased
to over 90% annually in the 12-13 year old cohorts, effectively reducing the prevalence
of HPV-16 and -18 from 29.8% to 13.6%.18 Additionally, there was a significant finding
that the bivalent vaccination also provided cross-protection against emerging HPV types
found to cause cervical cancer.
Australia, which implemented school-based delivery of the quadrivalent HPV
vaccine to 12-13 year old girls in 2007, decided in 2010 to extend the use of the vaccine
to boys and men up to age 26.19 Recognizing the risk that HPV poses to men who have
sex with men (MSM) in addition to the benefits to women from men receiving the
vaccine, Australian health officials have found that extending the vaccine to adolescent
and young men is not only cost-effective, but necessary to reduce the burden of HPVrelated disease. Georgousakis et al. (2012) indicate that practices in Australia can serve as
an example of how other countries can implement an immunization program which
maximizes coverage and is cost-effective.19
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The burden of HPV-related disease in the U.S. exacerbates rising healthcare costs
despite undeniable evidence the vaccines can reduce HPV incidence. 20 In the absence of a
national vaccination program similar to those proven successful in other high-income
countries,21 coverage rates are marginal in the U.S., primarily due to safety concerns and
controversy.2,16 In 2014, all three doses of the HPV vaccine were completed by 40% of
adolescent girls and 22% of boys in the U.S.,16 falling far below the objective of 80% as
outlined in Healthy People 2020.22 Despite a modest increase in vaccination since 2012
(particularly in young men), HPV vaccine coverage in the U.S. remains considerably
lower than other routine adolescent vaccines.16 Prelicensing studies specified that the
implementation of vaccination of males would be acceptable, though parents were still
more comfortable with vaccinating girls rather than boys for HPV.23
A systematic review conducted by Kessels et al. (2012) found that vaccine uptake
until 2011 (excluding males) was largely based on structural barriers such as having
health insurance, having a healthcare provider, and utilization of healthcare. 24 In addition,
the authors discovered that positive vaccine attitudes and higher vaccine knowledge also
played a major role in the uptake of the vaccine among teenaged girls as well as intention
to vaccinate. Negative predictors among parents of vaccine uptake were found to be
concerns regarding the safety of the vaccine, and possible negative side effects. Several
studies on parental acceptance of the HPV vaccine indicated that many parents felt that
vaccinating their child may lead to early initiation of sexual activity and even
promiscuity, prompting parents to delay vaccination of their child until they were
older.25–27 Despite widespread concerns related to sexuality and the HPV vaccine among
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parents across the world, multiple studies have indicated that receiving the vaccine has no
effect on sexual debut or increase of risky sexual behavior at any age. 28,29
College Students’ Knowledge of HPV
An early study found that of various STIs assessed, college students knew the
least about HPV, with 37% of students never even hearing of the virus. 30 Among female
students who reported being diagnosed with HPV, 68% had not heard of the virus before
being diagnosed. Men were less knowledgeable about HPV, despite their high
prevalence of HPV infection.
HPV knowledge deficits among college students have not been resolved: a 2012
survey of college males aged 18-25 found that 74% of the participants had not received
the HPV vaccination, and only 14.2% had completed the full series.31 This study also
found similar results as previous studies regarding knowledge of the virus and vaccine:
almost 50% of the respondents had never heard of HPV, nor were they aware that there
was a vaccine. Furthermore, many of the young men did not perceive risk for contracting
the virus. Participants also had low awareness that men should be vaccinated against
HPV, and low awareness that they fell within the age bracket recommended for
vaccination. These perceptions were common despite reporting low condom use and high
numbers of lifetime sexual partners. Compounded by the gender disparities in vaccination
uptake, knowledge deficits about HPV and HPV vaccine exist for ethnic and sexual
minorities, contributing to an increased risk in minority populations.32
Hispanic Attitudes toward HPV
Hispanics or Latinos are the largest, and fastest-growing minority population in
the U.S.33 They share a common language and culture, with attitudes and values that tend
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to differ from those of non-Hispanics. Hispanics are generally grouped as a single ethnic
category (independent of self-identified race), although they represent multiple
nationalities and are culturally heterogeneous.33
In the U.S., Hispanic women suffer from the highest cervical cancer incidence
rates, and Hispanic men have a higher incidence of HPV-associated penile cancer than
non-Hispanic men.34 These disparities prompted health agencies to prioritize Hispanics
for cervical cancer screening, STI prevention, and educational interventions. 35 Hispanics
are less likely to have heard of HPV or HPV vaccination than non-Hispanic whites.36
HPV-related knowledge has been examined as a determinant of HPV vaccine
acceptability and uptake; however, distinctions between Hispanics of different
demographic backgrounds are not often made.37,38 Immediately following the
recommendation for HPV vaccination, Hispanic rates of HPV vaccination uptake were
lower than non-Hispanic whites,39 although vaccine initiation is now higher among
Hispanics.40 Despite this, Hispanic parents are more likely to be concerned about vaccine
safety than non-Hispanic whites,38 yet are also more likely to follow a healthcare
provider’s recommendations and less likely to refuse a vaccine when recommended. 41
The majority of studies assessing HPV-related topics among men focused on
immunocompromised men or MSM, and rarely examined Hispanic men. 42–44 Heritage
and culture may play a large role in the healthcare decisions of Hispanic men, especially
in health-seeking behaviors such as vaccination.45 Beyond ethnic identity, the socially
constructed composite defining Hispanic masculinity and other gender norms may also
influence HPV knowledge and vaccination behaviors.46 Machismo has a role in framing
the views that health enables manhood, and the identity of manhood dictates health-
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seeking behaviors.45 Among 113 Hispanic college men surveyed in southeastern U.S.,
only 30% agreed that men were at risk for contracting HPV, and only 12% felt personally
threatened by that risk.45 Less than half intended on becoming vaccinated against HPV.
LGBTQ and HPV
Healthy People 2020 indicates that “improving health of LGBTQ is a public
health priority”.22 Whereas several studies describe the lack of knowledge and poor
perceptions of HPV risk among college students,47–50 limited data are currently available
about HPV knowledge and attitudes among LGBTQ university students. Despite having
similar prevalence as heterosexuals, many LGBTQ persons are less knowledgeable about
HPV, perceiving they are less susceptible to HPV and its effects due to sex behavior
differences.51
MSM have specific risks for anogenital warts and associated cancers, making this
often-overlooked group especially needy of the HPV vaccine, despite having consistently
low knowledge of HPV, similar to heterosexual males.52 Although LGBTQ are cited as a
public health priority, only 4.9% of MSM reported receiving any number of doses of
HPV vaccine as reported in the National HIV Behavioral Surveillance System in 2011. 53
Approximately 75.9% of the sample had visited a healthcare provider within the previous
year.51 A 2012 meta-analysis found anal HPV infection to be very common in MSM
(63.9%), especially in immunocompromised individuals (92.6%), many exhibiting signs
of anal cancer.54
Up to 30% of women who have sex with women (WSW) have a current HPV
infection, with up to 25% of WSW reporting diagnoses of cervical abnormalities, a rate
that is similar to heterosexual women.55 Despite the similarities between WSW and
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heterosexual women in this respect, many sexual minority women perceive that they are
less susceptible to HPV and its effects given the nature of their sexual activities. A recent
study found that from 2009-2012, WSW received the HPV vaccine at similar rates as
heterosexual women, although predictors of vaccine uptake were different for the two
groups.56
With so many studies consistently describing the lack of knowledge of HPV and
HPV vaccine among young women, and even more so among young men,
recommendations have been made that educational interventions be targeted at the young
adult population.52 The college and university setting create an optimal environment for
education about the virus and uptake of the vaccine, and possibly removing structural
barriers which prevent vaccination among those who are knowledgeable about the
vaccine. There is a need for HPV research with more diverse samples of men, especially
in southern states, a region which experiences some of the lowest HPV vaccination rates
in the country as well as some of the highest HPV infection incidence rates. 57 Many
studies30,58 concurrently indicate the need for implementing HPV educational and vaccine
promotion programs, as well as continued focus on the importance of male HPV
vaccination.59
It has been over ten years since the bivalent and quadrivalent HPV vaccines were
recommended in the U.S. With the recent licensure of an improved 9-valent HPV vaccine
in December 2014, increased global media attention has been paid to HPV related issues
of vaccine uptake and attitudes. 60,61 Barriers such as lack of knowledge and unsupportive
attitudes must be characterized to close the gap of vaccination uptake and health
disparities among genders, ethnicities, and sexual identities and orientations. 15 The
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proposed project represents a timely assessment of the progress that has been made in
increasing awareness and improving attitudes of this underutilized vaccine.
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CHAPTER III
Methodology
Sample
Institutional Review Board approval was obtained from Florida International
University’s Office of Research Integrity and granted through April 2017 for
implementation of the intervention and collection of survey data from approximately 400
participants enrolled in the FIU Women’s Studies course WST 3641: “LGBT and
Beyond: Non-Normative Sexualities in Global Perspective” (Appendix A). This IRB
protocol was amended in November 2016 to reflect the addition of data collection in the
course IDS 3189: “International Nutrition, Public Health and Economic Development” in
the semesters of fall 2016 and spring 2017 as a control group for the intervention. Survey
data were collected once per semester per course until spring 2017, with the exception of
fall 2015. The intervention group was a purposive sample; the womens’ studies course
was selected for this study due to the historical overrepresentation of LGBTQ students
enrolled. Students 18 years of age or older were eligible to participate in the study. Any
students who did not meet the age requirement were allowed to participate in educational
activities, but did not take part in survey data collection. Based upon a power analysis, a
sample size of 317 should have produced 80% power at the .05 level of significance to
detect expected effects based on a review of relevant literature. Enrollment of WST 3641
was between 65 and 90 students per semester.
Questionnaires
Pre- and post-tests, which were self-administered written surveys, were adapted
from the North Carolina Men’s Health Survey1,2 and developed by a team of graduate
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public health students in the spring semester of 2015 in the course PHC 6750: “Program
Implementation and Evaluation” (Appendix B). The pre-/post-test surveys were pretested
with a focus group of 16 graduate public health students. Each survey took approximately
five minutes to complete.
Demographic data were collected about the participants (age, gender identity,
ethnicity/race, health insurance status, relationship status, sexual practices), followed by
questions regarding current HPV vaccination status and willingness to receive the
vaccines. True/False questions were used to measure knowledge about HPV and the HPV
vaccine, and a five-point Likert scale was used to rate questions regarding attitudes
toward severity, susceptibility, and acceptability related to HPV and the available HPV
vaccines.
Data Collection
At the beginning of the designated class, students were read a brief statement
regarding voluntary participation and consent, then administered the pre-test survey.
After collection of the completed surveys, the students participated in an educational
intervention, which consisted of dissemination of HPV and HPV vaccination information
through a 30-minute PowerPoint presentation followed by a 10-15-minute question and
answer session. Post-intervention data were collected through the administration of the
post-test, which measured the same components as the pre-test, in addition to an
evaluation of the components of the intervention.
Data Analysis
The means, standard deviations, and other descriptive statistics were calculated
and subsequently analyzed by gender, sexual identity, and race/ethnicity to determine
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homogeneity between data collection points (semesters) and explore differences among
these groups. Some survey questions were reverse-scored so results can be analyzed with
all responses in the same direction. Wilcoxon-Rank Sum and repeated measures ANOVA
were performed on matched-pair (pre- and post-test) Likert questions to determine if
these differences were statistically significant. Binomial tests were performed to
determine post-intervention outcomes for students who specified “don’t know” on
baseline knowledge items. Analysis of covariance (ANCOVA) was used to determine
whether the post-intervention knowledge means, adjusted for pre-test scores, differed by
gender.3 Repeated measures ANOVA were also used to assess if the intervention
influenced mean change in knowledge scores from pre to post differed by independent
variables. Pearson’s Chi-Square test or Fisher’s Exact test was performed to determine
differences in between and among groups and categorical variables, and CochraneMantel-Haenszel tests characterized individual pre- versus post-intervention categorical
measures stratified by certain demographic characteristics. Statistical significance was set
at P<0.05. All analyses were performed using SPSS 20.0.5
Pilot Testing
Intervention planning and implementation are iterative processes. Each time the
intervention was carried out is a learning experience for not only the participants, but the
researchers as well. Process evaluations of the pilot intervention conducted in April 2015
prompted enhancements for the presentation component of the intervention, as well as the
surveys.
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Summary of Pilot Findings
Selected intervention evaluation results of the pilot study were presented the 30 th
International Papillomavirus Conference in September 2015.4 LGBTQ students (n=38)
were similar to heterosexual students (n=43) regarding demographic characteristics and
lifetime sexual experiences (Table 1.1).

Table 3.1 Differences Between LGBT and Heterosexual Students

LGBTQ students found the question and answer session more useful and rated the
overall session “very positive” (P<0.10) (Table 1.2).

Table 3.2 Student Responses Regarding a Brief HPV Educational Intervention
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All participants regarded the session helpful in formulating a decision about
vaccine uptake (Table 3). Thirty-five percent expressed strong intentions to be vaccinated
after the classroom intervention (P=.04).

Table 3. Intervention Results by Student Sexuality
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CHAPTER IV
Are Men Being Left Behind (Or Catching Up)? Gender Differences in HPV-Related
Awareness, Knowledge, and Attitudes Among Diverse College Students
Abstract
Objective: We assessed awareness, knowledge, and attitudes about human
papillomavirus (HPV). Participants: From April 2015 to February 2017, 386
undergraduates were recruited in a South Florida university. Methods: A survey of HPVrelated awareness, knowledge, and attitudes was designed and conducted. Results: Most
(84%) had heard of HPV, and 70% had favorable attitudes toward vaccination. Only 28%
of men and 55% of women had received ≥1 dose vaccine, 4% reported receiving three
doses. Those with 1 dose were more knowledgeable about HPV (P=0.01). High
knowledge scores were recorded for 30% of respondents, and strongly associated with
perceived knowledge (P<0.001). Negative attitudes toward HPV vaccine acceptance
were associated with low knowledge scores and undervaccination. Conclusions: HPV
knowledge and vaccine uptake remain problematic among college students, and both are
associated with negative HPV vaccine attitudes. HPV educational efforts should target
young men as HPV-related cancer morbidity continues to rise in men.

Key Words: HPV, College Students, HPV Vaccine, Awareness, Knowledge, Attitudes
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Introduction
Human papillomavirus (HPV) infection is the most common sexually transmitted
infection (STI) in the world.1 Although most HPV-infected persons clear the virus
completely, HPV causes multiple adverse clinical outcomes in both men and women.
Due to the long-established connection between some HPV subtypes and cervical cancer,
women were initially thought to be the only population burdened by the virus’ clinical
outcomes,2,3 resulting in treatment and prevention solutions solely targeting women.4–6
Several studies estimate that HPV incidence and prevalence in men are similar to
women’s, although substantial variability may exist by location and population.7 This
evidence has shown HPV to be the cause of over 90% of genital warts in men, who
experience a longer duration of this outcome than women, and incur more treatment
costs. HPV is also responsible for the majority of male anal, oropharyngeal, and penile
cancers,8,9 creating substantial health and economic burden beyond that of cervical
cancer. The direct medical costs of HPV-related outcomes in the U.S. were estimated to
be $1.7B in 2008.10 HPV-related cases of oropharyngeal cancers in otherwise healthy
men will soon surpass the number of cervical cancer cases in the U.S. 11 Despite this
trend, men’s knowledge and attitudes toward HPV have continued to lag behind
women’s, a seemingly continuous effect of previous female-focused prevention efforts.
The Advisory Committee on Immunization Practices has recommended safe and
effective HPV vaccination for 9-26 year old girls and women since 2006.12 Substantial
decreases in vaccine-preventable HPV subtype infections were evident after only the
sixth year of vaccine implementation in the U.S.; a 64% decrease was observed among
those 14-19 years and a 34% decrease among those 20-24 years.13 The quadrivalent HPV
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vaccine was additionally recommended for boys and young men in 2011.12 Despite its
proven success, HPV vaccination rates among boys and men in the U.S. are far below the
recommended Healthy People 2020 target of 80% coverage easily achieved for other
routine vaccines.14
For college students, HPV infection constitutes a substantial threat considering
this population’s increased sexual activity and sexual risk-taking.15–17 College-aged
young adults (20-24 years old) have the highest prevalence of anogenital HPV
infection.8,13 Most universities provide onsite medical facilities for students, offering
HPV vaccination and education among other preventive services. 18 Despite the
availability of these services, HPV-related knowledge in college students may be low
compared to other STIs, especially among young men.19 The sluggishly growing HPV
vaccination rates leave a large population of college-aged young adults unprotected,
despite eligibility to receive catchup doses.20 Several studies report that vaccine
acceptability is correlated with awareness and knowledge about HPV,21–24 yet until
recently, little research has included college-aged men’s attitudes toward HPV
vaccination.25–27
Research focused on characterizing disparities in awareness and knowledge is
especially needed in ethnically diverse areas such as the state of Florida, which has some
of the lowest HPV vaccination rates in the country, as well as some of the highest
cervical cancer rates.28 Evaluating what men and women in college know, think, and do
about the threat of HPV can offer possible solutions to remedy the underutilization of the
HPV vaccine in a population at high risk for contracting this preventable infection. This
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report explores differences in HPV-related awareness, knowledge, attitudes, and practices
among college students in south Florida.
Methods
A cross-sectional study of university students focusing on students’ HPV-related
awareness and knowledge, as well as attitudes and uptake of HPV vaccination, was
conducted from March 2015- February 2017. The university’s institutional review board
granted exempt approval status prior to study implementation.
Participants
Men and women registered in four sections (semesters) of an undergraduate
gender studies course taught by the same instructor from March 2015- February 2017
were recruited for this study. Additionally, students enrolled in undergraduate public
health and dietetics courses in January and February of 2017 were recruited. Students
aged 18 or older who were present on the day of data collection were invited to
participate by completing a questionnaire. Participants were read a brief statement
regarding voluntary participation and consent. Students were not required to answer
every item or return the questionnaire to the study team.
Students were included in the current study if they were (a) 18 years or older at
the time of data collection, (b) registered for the college course in which data collection
took place, and (c) were present in class at commencement of data collection.
Survey Procedures
At the time of data collection, the research team explained the purpose of their
visit to the class and presented the statement of informed consent. Participants under the
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age of 18 years were identified and excluded from participation, but were welcome to
remain in the classroom. Written, self-administered questionnaires were then distributed
to eligible participants. The survey took approximately 5-10 minutes to complete. Upon
completion surveys were deposited by each student into a large envelope or box carried
by circulating research team members. Participants received tokens of appreciation for
their time, such as promotional pens, pencils, lip balm, and condoms.
Measures
The questionnaire consisted of 34 items. Nine were sociodemographic or
descriptive items. Eighteen items were adapted from the 100-item 2009 University of
North Carolina Men’s Health Survey.25,29 The remaining items were developed in March
2015 after a review of the literature and were based on the aims of the current study.
Questionnaires were pretested with a focus group of 16 graduate public health students
and revised based on feedback received (questionnaire is available from authors upon
request).
Sociodemographic and baseline data (i.e. age, gender identity, ethnicity/race,
health insurance status, sexual orientation, relationship status, sexual activities, and
number of partners) were self-reported. Awareness of HPV was assessed with a single
question that asked participants, “Have you heard of HPV or human papillomavirus
before today?” (yes, no, don’t know). Participants then indicated how many doses of
HPV vaccine they had received as of that day (0, 1, 2, 3, don’t know), and subsequently if
they were not already fully vaccinated, if they were willing to take the HPV vaccine (yes,
no, don’t know). Participants also responded to the question, “Before today, I have never
thought of getting the HPV vaccine for myself” (yes, no, don’t know).
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Eleven questions measured beliefs about various HPV-related statements on a
five-point Likert scale ranging from “strongly agree” to “strongly disagree” with an
additional “don’t know” option. We developed an ad-hoc scale consisting of the five
Likert items specifically addressing vaccination. We found the Carolina HPV
Immunization Attitudes and Beliefs Scale by McRee et al. 30 for caregivers and adapted
by Dempsey et al.31 for young women to be well suited for our investigation, but too
lengthy for inclusion in our brief questionnaire. Our scale succinctly gauged participants’
attitudes toward the HPV vaccine, who are appropriate recipients, and vaccines in general
(e.g., “Vaccines in general are safe and effective,” “My opinion of the HPV vaccine is
mostly positive”). Items were coded such that “strongly agree” or “agree” corresponded
to a positive attitude toward that topic. Reliability assessment of the vaccine attitudes
scale was conducted with Cronbach’s alpha (n=397, α=0.91).
Participants were then asked to describe their perceived level of knowledge of
HPV and the vaccine in two separate questions as “Nothing at all,” “a little,” “a moderate
amount,” or “quite a lot”. Aside from respondents’ reported self-perceived knowledge
related to HPV, we measured knowledge with seven true/false items. We created a
composite knowledge score by summing the number of correct responses (maximum of
seven total). Respondents’ knowledge was categorized as either high (four or more
questions correct) or low (three or less questions correct). Knowledge items included
questions such as “Some strains of HPV are harmless” (True) and “The HPV virus causes
herpes in men and women” (False). Participants were not required to answer each
question before proceeding to the next. We report percentages for the complete sample,
and percentages (n/N) when analyses contain missing data.
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Data Analysis
Univariate means or percentages were first calculated for sociodemographic
variables in the entire sample and then by gender. Descriptive statistics were
subsequently calculated to determine homogeneity between data collection points and
sites (semesters and courses). When differences were negligible, data were pooled.
Categories for items regarding awareness of HPV and number of doses categories
were collapsed into dichotomous outcomes. Likert questions were collapsed into
“Strongly Agree/Agree”, “Disagree/Strongly Disagree”, and “Neutral/Don’t Know”.
Likert items were reverse-scored if necessary to allow results to be analyzed together.
Demographic differences in the knowledge score and HPV attitudes scale were
determined using Pearson’s chi-square test.
We then explored correlates of five HPV-related outcomes: awareness, self-perceived
knowledge, measured knowledge (score), willingness to vaccinate, and vaccine beliefs (scale).
Sociodemographic characteristics such as age, gender, race, ethnicity, health insurance status,
HPV awareness, and HPV vaccine uptake were among potential correlates.
A post-hoc power analysis was conducted with GPower,32 which indicated a sample size
of 358 was needed to detect effect sizes of w=0.5 for tests of independence. Statistical
significance was set at P<0.05. All analyses were performed using SPSS 20.0.33
Results
Sample Characteristics
Of the 409 students eligible to participate, 389 (95%) completed the survey and
were included in the current analysis. Three participants were under the age of 18 and
were excluded. Participants had a mean age of 22.3 years (SD=4.9) and were mostly
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female (70%). Approximately two-thirds were Hispanic (66%) and single (66%), and
over half identified their race as white (59%). Less than two thirds (62%) identified their
orientation as heterosexual/straight and 55% reported between one and five lifetime
sexual partners at the time of survey. Men were more likely to report greater than ten
lifetime sexual partners than women (28% vs. 10%, respectively). Students reported ever
having more oral (80%) and vaginal (69%) lifetime sexual experience than anal sex
experience (36%). Fourteen percent reported having no lifetime sexual partners. Over
three-fourths reported having health insurance coverage (78%; Table 1).
HPV Awareness and Vaccination Status
Overall, most participants (84%) had heard of HPV; more women were aware of
the virus than men (86% versus 77%, respectively), although this difference was not
significant (P=0.07). Number of lifetime sex partners was not associated with HPV
awareness; however, participants who reported being single were less likely to be aware
of HPV than those in a relationship (P=0.01). No significant differences were found by
race (Black, White, other), insurance status, or age.
Despite being mostly aware of HPV, the majority (60%) of participants had not
received any HPV vaccine doses or did not know their vaccination status at the time of
survey. Participants who had received any doses of HPV vaccine were more likely to
report having heard of HPV (𝑃 ≤0.001; Table 2). While 40% of respondents had at least
one dose of HPV vaccine, only 15.3% had received three doses. Significant vaccination
differences by gender were evident; 72% of men had received no or an unknown number
of doses of HPV vaccine compared to 55% of women (P=0.01). Only 4% of men in this
sample had all three doses compared to 26% of women (P≤0.001). Forty-five percent of
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men and 27% of women said they had never thought about getting the HPV vaccine for
themselves (an additional 23% of men said they don’t know; P<0.001).
Perceived and Measured HPV-Related Knowledge
In response to the question “How much would you say you know about HPV?”
(perceived knowledge), 69% of men and 62% of women perceived that they knew
nothing or little (NS), and even more reported knowing nothing or little about the HPV
vaccine (72% men and 67% women, NS). Seventy percent of participants scored low (3
correct out of seven) on the True/False knowledge section. There were no significant
gender differences in overall mean knowledge score; men earned an average score of 2.1
out of seven (SD=2.1), and women earned an average of 2.5 (SD=1.9, NS). Despite this,
men (38%) were more likely than women (24%) to score zero points (P=0.005). Only
seven participants (1.8%) answered all seven questions correctly (Figures 1 and 2).
Age group was significantly associated with knowledge score; 82% of 18-20-year
olds in this sample were categorized as having low knowledge versus 62% of 21-23-year
olds (P<0.001). A simple main effects analysis showed that age group was not a
statistically significant influence on men’s knowledge scores (F(1, 106)=0.13, P=0.72).
However, age was a significant factor in women’s HPV knowledge score (F(3,
256)=11.3, P<0.001). Age was further analyzed in women by pairwise comparisons
using Tukey’s post-hoc test, which showed that women in the 18-20-year-old age group
had a significantly lower mean knowledge score than the other three age groups, and
knowledge progressively increased with age group (P<0.001; Figure 3).
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Half or more of respondents incorrectly identified herpes or AIDS as diseases
caused by HPV (58% and 50%, respectively), with no significant differences by gender.
Participants who received any doses of HPV vaccine (47%) or had >10 lifetime sexual
partners (46%) were significantly more likely to score high on the knowledge items than
others (P≤0.001 and P=0.02, respectively).
There was a strong relationship between perceived and actual HPV-related
knowledge. Respondents who characterized their HPV-related knowledge as low (77%)
earned low knowledge scores (P≤0.001). Only 51% of those with a high score perceived
themselves to be knowledgeable. Similar to knowledge score and age, there was a
significant difference in gender. A simple main effects analysis showed that men’s
perceived knowledge was not independently associated with men’s knowledge scores
(F(1, 109)=2.6, P=0.11). However, among women, perceived knowledge was
significantly associated with HPV knowledge score (F(1, 263)=12.7, P<0.001), with
women who perceived to know moderate/a lot about HPV performing better in
knowledge score (M=3.0, SE=0.19) than those who perceived themselves to have
no/little HPV knowledge (M=2.1, SE=0.15, P<0.001).
Vaccine Attitudes
In response to the five-item vaccine attitudes scale, 70% of total participants
reported positive attitudes toward HPV vaccination, with men and women responding
similarly. Number of doses of HPV vaccine received was significantly associated with
vaccine attitudes; an association which differed between men and women (2MH(1)=30.9,
P<0.001). Vaccinated women were over seven times more likely than unvaccinated
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women to report positive vaccine attitudes (RR=7.1, CI[3.3-15.5]). This contrasts with
men, whose vaccination status was not significantly associated with vaccine attitudes
(RR=2.9, CI[0.9-8.7]).
Of the participants reporting negative attitudes toward vaccines, 85% had
received either zero or an unknown number of HPV vaccinations (2=31.8, P<0.00).
Eighty percent of participants with negative HPV vaccine attitudes scored low (≤3/7) on
the measured knowledge portion of the questionnaire (2=7.6, P=0.01). Of those not
vaccinated or undervaccinated (vaccine series initiated but incomplete), 58% were
willing to receive the HPV vaccine, and 27% did not know if they wanted to be
vaccinated. Participants who had heard of HPV before the day of the survey were more
willing to be vaccinated than those who had not heard of the virus before (67% vs 27%;
2=34.8, P<0.001).
Comment
Vaccinating both men and women against HPV is essential to protect against the
rising HPV-related cancer rate. We focused on gender differences in HPV awareness,
HPV vaccine uptake, perceived and actual HPV knowledge, and vaccine attitudes. Men
in our sample appeared to be catching up to women in awareness and knowledge, though
women were still ahead in HPV vaccine uptake and vaccination intentions.
Awareness
Men and women had high levels of HPV awareness (>80%). In 1999, college
students were largely oblivious to HPV; only 37% of students at a Florida university had
ever heard of the virus.34 Although men were less aware than women, we found no
statistically significant difference in 2015-2017. The gender disparity gap may be closing
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as overall awareness increases among both men and women, an apparent improvement
compared with earlier research that showed college women were significantly more
aware of HPV than college men.28,35–37
Perceived and Measured Knowledge
Despite high levels of HPV awareness among undergraduate students in South
Florida, both men and women reported disconcertingly low levels of perceived and
measured knowledge on the topic. Poor knowledge scores, especially among the
youngest participants, who would have the most to benefit from vaccination, confirmed
their self-perceptions. A staggering 38% of men in our study answered no questions at all
correctly on HPV knowledge. Our results are consistent with previous studies indicating
that despite being acutely aware of HPV and HPV vaccination, significant knowledge
deficits persist regarding how HPV is transmitted, what diseases result from HPV
infection, as well as how to prevent infection effectively. Of various STDs evaluated in
the late 1990s and early 2000s, college students knew the least about HPV, 34,38 and as in
our study, they confused HPV outcomes with herpes simplex virus or HIV.39
The youngest women in our sample received significantly lower scores than
women in older age groups, similar to findings in previous research on age differences.39
HPV knowledge disparities by age may be explained by older women having more
encounters with sexual health education, HPV screening in the medical setting, knowing
someone who has been diagnosed with an HPV infection or related disease, or
experiencing infection themselves.39
After the quadrivalent vaccine was introduced and approved for girls and women
in 2006, there was intense marketing from the pharmaceutical manufacturers and health
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agencies, but the manufacturer’s decision to market the vaccine to middle class
consumers as an “anticancer vaccine” effectively detached cervical cancer from its
sexually transmitted origins, and gender nonspecificity.40 A campaign that provided little
HPV information possibly may have increased awareness, but failed to increase scientific
knowledge.41 Low knowledge combined with high awareness may also reflect a lack of
comprehensive sexual education during the formative years. For over 20 years, Florida
public schools have adhered to an abstinence-only or abstinence-based sexual health
curriculum.42 Despite this mandate, Florida lacks consistent state standards for the sexual
education that is provided, with many students receiving no sexual health education at all.
These results highlight the need for comprehensive sexual health education at all ages,
whether it is received from a health care provider, school-based program, or another
reliable source.
Attitudes
We were interested in exploring attitudes toward HPV vaccination, and how those
attitudes may be associated with vaccination intentions and behaviors. Over 70% of men
had not been vaccinated in our study, and only 26% of women and 4% of men had
received all three doses of HPV vaccine, despite men reporting similar awareness and
knowledge as women. Participants reported favorable vaccine attitudes (70%), yet
vaccinated women were seven times more likely to have positive views of vaccination
than unvaccinated women, a distinction not observed in young men.
The first vaccines approved in 2006 were initially promoted for girls, creating
earlier mindfulness of HPV and prevention among them. Previous studies with young
men have found that acceptability of the HPV vaccine has varied from modest (33%–
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48%) to high (78%).21,23,43,44 In the past, the case has been made for altruistic motivation
for men to be vaccinated, thereby protecting women through their vaccination. 45
However, the steep rise in HPV-related oropharyngeal cancer morbidity in men and the
potential protective effect of the HPV vaccine for oropharyngeal infection46,47 suggest an
urgent need to improve vaccine uptake in men to protect themselves from adverse
consequences to their health.
Those with negative attitudes toward HPV vaccination were overwhelmingly
uninformed about HPV, and were likely to be unvaccinated. The positive correlation
between a favorable attitude and vaccine uptake may be an effect of attitude-behavior
consistency. Longitudinal attitude studies have found that positive correlations between
attitude and behavior strengthen as a function of information available on the topic, as
well as direct experience with the attitude object.48,49 In our sample, those with positive
attitudes tended to be more knowledgeable, but were also more likely to have already
received at least one dose of HPV vaccine.
Limitations
Limitations of this study include its cross-sectional nature, which precludes ability
to infer causation or establish a temporal connection in variables of interest, such as HPV
knowledge and vaccine uptake. This study used a non-probability sample to maximize
diversity, thus, generalizability is limited. We collected self-reported data from the
participants, which may subject our results to social desirability and recall biases.
Our study was conducted in an urban area of south Florida, a state among those
with the highest percentages of Hispanic and foreign-born residents.50 Florida
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(specifically Miami-Dade County) also leads the country in number of Cuban-descent
residents, who are typically not representative of Hispanics from other countries.
Despite these limitations, these results provide evidence that a significant number
of young adults in the U.S. lack accurate knowledge about HPV, the HPV vaccine, and
the importance of preventing HPV infection.
Implications and Future Research
Our results suggest that educational interventions should be delivered to increase
knowledge and change attitudes toward HPV and HPV vaccination among college
students, especially men and freshman women. The college setting provides an optimal
environment for education about the virus and uptake of the vaccine. Furthermore,
student health centers can assist in removing structural barriers which prevent vaccination
among those who are knowledgeable.51,52
Future research can integrate these findings to fine-tune which populations should
be targeted, and support research aimed at improving knowledge and attitudes regarding
HPV among men. Qualitative research can be conducted with at-risk groups, such as
men, to inform the design and development of tailored interventions. This type of
research would be useful in determining what messages are suitable for this population,
as well as who provides messages, where messages are delivered, and which approaches
should be utilized.27
To expedite the achievement of state and national vaccination goals, several
actions can be pursued. Florida and other states can review options for the
implementation and evaluation of comprehensive sexual education for elementary,
middle, and high school students. Many studies have reported support for such programs
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from both teachers and parents.42,53 Because there is not a cure for HPV and other viral
STIs, primary prevention is essential. Florida and other states may in the future follow the
lead of states such as Virginia, Rhode Island, and the District of Columbia in requiring
HPV vaccination for school matriculation along with other routine vaccinations. 54
In 2012, former Florida Senator Thad Altman introduced Senate Bill 146,
requiring that parents and caregivers of students entering grade six at least be given
information about HPV, related diseases, and the availability of vaccines to prevent its
transmission.54 The bill died in the Health Policy Committee. In January 2018, Senate
Bill 1558 was introduced in Florida by Miami Senator Jose Javier Rodriguez which
would make it mandatory for 11 and 12-year olds attending public school to become
vaccinated against HPV.56 The bill died in the Health Policy Committee.
If HPV vaccination were also required for college matriculation, dramatic
reductions in HPV-related outcomes might be seen. For young adults, increased genderinclusive, targeted information for college students in clinical settings would reinforce
health promotion messages. To remove barriers such as cost and access, student health
centers and clinics could determine mechanisms to offer HPV vaccination to students free
of charge. Providers could conduct a vaccine eligibility assessment at each visit,
regardless of gender, and during general non-STD visits also. National vaccine registries
and reporting systems should be integrated and intuitive for clinicians, which would help
strengthen vaccine reporting and support vaccine recommendation equality.
Conclusions
Carrying the majority of the HPV burden, there is a distinct opportunity for
preventive measures to be improved among 18-26 year olds across the country. Our
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findings indicate the need for aggressive targeting of young adults for education and
behavioral intervention, with particular attention on young men. Despite general
awareness of “HPV” and “HPV vaccine” as hot-button terms, participants in this study
demonstrated an astonishing lack of detailed knowledge about HPV, which is associated
with negative vaccine attitudes and uptake. Knowledge among young men seems to be
slowly improving, yet these deficits place unreasonable burden on women to protect
against a virus that increasingly affects men. Increased knowledge about young adults’
awareness, knowledge, and attitudes toward HPV and HPV vaccination is imperative to
reach the goal of 80% HPV vaccination coverage to reduce the burden of HPV-related
disease in the U.S.

References
1.

US Department of Health and Human Services. Human Papillomavirus (HPV)
Infection - 2015 STD Treatment Guidelines Website.
https://www.cdc.gov/std/tg2015/hpv.htm. Published 2015. Accessed July 31,
2017.

2.

Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnürch HG, zur Hausen H.
Human Papillomavirus types 6 and 11 DNA Sequences in Genital and Laryngeal
Papillomas and in Some Cervical Cancers. Proc Natl Acad Sci U S A.
1983;80(2):560-563.

3.

Walboomers JMM, Jacobs M V., Manos MM, et al. Human Papillomavirus is a
Necessary Cause of Invasive Cervical Cancer Worldwide. J Pathol.
1999;189(1):12-19. doi:10.1002/(sici)1096-9896(199909)189:1<12::aidpath431>3.0.co;2-f.

4.

Jain A, Barone M. Preventing Cervical Cancer. AVSC News. 1996;34(3):2.

5.

Slater JS, Bar-Cohen A, Korn JE, Yawn B. Preventing cervical cancer. Minn Med.
1994;77(5):25-26.

6.

Celentano DD, Klassen AC, Weisman CS, Rosenshein NB. Cervical Cancer
Screening Practices among Older Women: Results From the Maryland Cervical

46

Cancer Case-Control Study. J Clin Epidemiol. 1988;41(6):531-541.
doi:10.1016/0895-4356(88)90057-1.
7.

Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of
HPV Infection among Men: A Systematic Review of the Literature. J Infect Dis.
2006;194(8):1044-1057. doi:10.1086/507432.

8.

Giuliano AR, Lu B, Nielson CM, et al. Age-Specific Prevalence, Incidence, and
Duration of Human Papillomavirus Infections in a Cohort of 290 US Men. J
Infect Dis. 2008;198(6):827-835. doi:10.1086/591095.

9.

Colón-López V, Ortiz AP, Palefsky J. Burden of Human Papillomavirus Infection
and Related Comorbidities in Men: Implications for Research, Disease Prevention
and Health Promotion among Hispanic Men. PR Health Sci J. 2010;29(3):232240.

10.

Owusu-Edusei K, Chesson HW, Gift TL, et al. The Estimated Direct Medical
Cost of Selected Sexually Transmitted Infections in the United States, 2008. Sex
Transm Dis. 2013;40(3):197-201. doi:10.1097/OLQ.0b013e318285c6d2.

11.

Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human Papillomavirus and Rising
Oropharyngeal Cancer Incidence in the United States. J Clin Oncol.
2011;29(32):4294-4301. doi:10.1200/JCO.2011.36.4596.

12.

Meites E, Kempe A, Markowitz L. Use of a 2-Dose Schedule for Human
Papillomavirus Vaccination- Updated Recommendations of the Advisory
Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep.
2016;65(49):1405-1408. doi:10.15585/mmwr.mm6549a5.

13.

Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of
HPV After Introduction of the Vaccination Program in the United States.
Pediatrics. 2016;137(3). doi:10.1542/peds.2015-1968

14.

Department of Health and Human Services. Healthy People 2020 website.
https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-andinfectious-diseases/objectives. Accessed October 10, 2017.

15.

Grello CM, Welsh DP, Harper MS. No Strings Attached: The Nature of Casual
Sex in College Students. Source J Sex Res. 2006;43(3):255-267.

16.

Wechsler H, Dowdall GW, Davenport A, Castillo S. Correlates of College
Student Binge Drinking. Am J Public Health. 1995;85(7):921-926.
doi:10.2105/AJPH.85.7.921.

17.

Guttmacher A. Sex and America’s Teenagers. New York: Alan Guttmacher
Institute; 1994.

47

18.

Barnett KS, Shoben AB, McRee A-L, Reiter PL, Paskett ED, Katz ML. Human
Papillomavirus Vaccine and Pap Tests on College Campuses: How Do
Historically Black Colleges and Universities (HBCUs) Measure Up? J Am Coll
Heal. 2016;64(8):613-618. doi:10.1080/07448481.2016.1213731.

19.

Fontenot HB, Fantasia HC, Charyk A, Sutherland MA. Human Papillomavirus
(HPV) Risk Factors, Vaccination Patterns, and Vaccine Perceptions Among a
Sample of Male College Students. J Am Coll Heal. 2014;62(3):186-192.
doi:10.1080/07448481.2013.872649.

20.

Mehu-Parant F, Rouzier R, Soulat JM, Parant O. Eligibility and Willingness of
First-Year Students Entering University to Participate in a HPV Vaccination
Catch-Up pPogram. Eur J Obstet Gynecol Reprod Biol. 2010;148(2):186-190.
doi:10.1016/j.ejogrb.2009.10.024.

21.

Ferris DG, Waller JL, Miller J, et al. Variables Associated With Human
Papillomavirus (HPV) Vaccine Acceptance by Men. J Am Board Fam Med.
2009;22(1):34-42. doi:10.3122/jabfm.2009.01.080008.

22.

Gerend MA, Barley J. Human Papillomavirus Vaccine Acceptability Among
Young Adult Men. Sex Transm Dis. 2009;36(1):58-62.
doi:10.1097/OLQ.0b013e31818606fc.

23.

Lenselink CH, Schmeink CE, Melchers WJG, et al. Young Adults and
Acceptance of the Human Papillomavirus Vaccine. Public Health.
2008;122:1295-1301. doi:10.1016/j.puhe.2008.02.010.

24.

Hunter T, Weinstein M. Beliefs and Knowledge about the Human Papillomavirus
Vaccine among Undergraduate Men. Health Educ J. 2016;75(2):249-256.
doi:10.1177/0017896915572705.

25.

Brewer NT, Ng TW, Mcree A-L, Reiter PL. Men’s Beliefs About HPV-Related
Disease. J Behav Med. 2010;33(4):274-281. doi:10.1007/s10865-010-9251-2.

26.

Fitzgerald SM, Savage EB, Hegarty JM. The Human Papillomavirus: Men’s
Attitudes and Beliefs Toward the HPV Vaccination and Condom Use in Cancer
Prevention. J Men’s Health. 2014;11(3):121-129. doi:10.1089/jomh.2014.0022.

27.

Catalano HP, Knowlden AP, Birch DA, Leeper JD, Paschal AM, Usdan SL.
Using the Theory of Planned Behavior to Predict HPV Vaccination Intentions of
College Men. J Am Coll Heal. 2017;65(3):197-207.
doi:10.1080/07448481.2016.1269771.

28.

Fontenot HB, Fantasia HC, Sutherland MA, Lee-St. John T. HPV and HPV
Vaccine Information among a National Sample of College and University

48

Websites. J Am Assoc Nurse Pract. 2016;28(4):218-223. doi:10.1002/23276924.12312.
29.

Reiter PL, Brewer NT, McRee A-L, Gilbert P, Smith JS. Acceptability of HPV
Vaccine among a National Sample of Gay and Bisexual Men. Sex Transm Dis.
2010;37(3):197-203. doi:10.1097/OLQ.0b013e3181bf542c.

30.

McRee AL, Brewer NT, Reiter PL, Gottlieb SL, Smith JS. The Carolina HPV
Immunization Attitudes and Beliefs Scale (CHIAS): Scale Development and
Associations with Intentions to Vaccinate. Sex Transm Dis. 2010;37(4):234-239.
doi:10.1097/OLQ.0b013e3181c37e15.

31.

Dempsey AF, Fuhrel-Forbis A, Konrath S. Use of the Carolina HPV
Immunization Attitudes and Beliefs Scale (CHIAS) in young adult women. PLoS
One. 2014;9(6). doi:10.1371/journal.pone.0100193.

32.

Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A Flexible Statistical
Power Analysis Program for the Social, Behavioral, and Biomedical Sciences.
Behav Res Methods. 2007;39:175-191.

33.

IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp.; 2011.

34.

Yacobi E, Tennant C, Ferrante J, Pal N, Roetzheim R. University Students’
Knowledge and Awareness of HPV. Prev Med. 1999;28:535-541.
doi:10.1006/pmed.1999.0486.

35.

Gerend MA, Magloire ZF. Awareness, Knowledge, and Beliefs about Human
Papillomavirus in a Racially Diverse Sample of Young Adults. J Adolesc Heal.
2008;42:237-242. doi:10.1016/j.jadohealth.2007.08.022.

36.

Sandfort JR, Pleasant A. Knowledge, Attitudes, and Informational Behaviors of
College Students in Regard to the Human Papillomavirus. J Am Coll Heal.
2009;58(2):141-149.

37.

Osazuwa-Peters N, Adjei Boakye E, Mohammed KA, Tobo BB, Geneus CJ,
Schootman M. Not Just a Woman’s Business! Understanding Men and Women’s
Knowledge of HPV, the HPV Vaccine, and HPV-Associated Cancers. Prev Med.
2017;99:299-304. doi:10.1016/J.YPMED.2017.03.014.

38.

Bynum SA, Brandt HM, Friedman DB, Annang L, Tanner A. Knowledge,
Beliefs, and Behaviors: Examining Human Papillomavirus-Related Gender
Differences among African-American College Students. J Am Coll Heal.
2011;59(4):296-302. doi:10.1080/07448481.2010.503725.

49

39.

Garcini LM, Murray KE, Barnack-Tavlaris JL, Zhou AQ, Malcarne VL, Klonoff
EA. Awareness and Knowledge of Human Papillomavirus (HPV) among
Ethnically Diverse Women Varying in Generation Status. J Immigr Minor Heal.
2015;17(1):29-36. doi:10.1007/s10903-013-9913-6.

40.

Fernandez BC. “I Want to Be One Less”: The Rhetoric of Choice in Gardasil Ads.
Commun Rev. 2012;15(2):144-158. doi:10.1080/10714421.2012.674462.

41.

Rothman SM, Rothman DJ. Marketing HPV Vaccine. JAMA. 2009;302(7):781786. doi:10.1001/jama.2009.1179.

42.

Barr EM, Moore MJ, Johnson T, Forrest J, Jordan M. New Evidence: Data
Documenting Parental Support for Earlier Sexuality Education. J Sch Health.
2014;84(1):10-17. doi:10.1111/josh.12112.

43.

Brewer NT, Fazekas KI. Predictors of HPV Vaccine Acceptability: A TheoryInformed, Systematic Review. Prev Med. 2007;45:107-114.
doi:10.1016/j.ypmed.2007.05.013.

44.

Reiter PL, Brewer NT, Smith JS. Human Papillomavirus Knowledge and Vaccine
Acceptability among a National Sample of Heterosexual Men. Sex Transm Infect.
2010;86:241-246. doi:10.1136/sti.2009.039065.

45.

Bonafide KE, Vanable PA. Male Human Papillomavirus Vaccine Acceptance is
Enhanced by a Brief Intervention That Emphasizes Both Male-Specific Vaccine
Benefits and Altruistic Motives. Sex Transm Dis. 2015;42(2):76-80.
doi:10.1097/OLQ.0000000000000226.

46.

Chaturvedi AK, Graubard BI, Broutian T, et al. Effect of Prophylactic Human
Papillomavirus (HPV) Vaccination on Oral HPV Infections among Young Adults
in the United States. J Clin Oncol. 2018;36(3):262-267.
doi:10.1200/JCO.2017.75.0141.

47.

Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence Trends for
Human Papillomavirus-Related and -Unrelated Oral Squamous Cell Carcinomas
in the United States. J Clin Oncol. 2008;26(4):612-619.
doi:10.1200/JCO.2007.14.1713.

48.

Fabrigar LR, Petty RE, Smith SM, Crites SL. Understanding Knowledge Effects
on Attitude-Behavior Consistency: The Role of Relevance, Complexity, and
Amount Of Knowledge. J Pers Soc Psychol. 2006;90(4):556-577.
doi:10.1037/0022-3514.90.4.556.

50

49.

Davidson AR, Yantis S, Norwood M, Montano DE. Amount of Information
About the Attitude Object and Attitude-Behavior Consistency. J Pers Soc
Psychol. 1985;49(5):1184-1198. Accessed April 2, 2018.

50.

Pinheiro PS, Sherman RL, Trapido EJ, et al. Cancer Incidence in First Generation
U.S. Hispanics: Cubans, Mexicans, Puerto Ricans, and New Latinos. Cancer
Epidemiol Biomarkers Prev. 2009;18(8):2162-2169.

51.

Dillard JP, Spear ME. Knowledge of Human Papillomavirus and Perceived
Barriers to Vaccination in a Sample of US Female College Students. J Am Coll
Heal. 2006;59(3):186-190.

52.

Fontenot HB, Fantasia HC, Vetters R, Zimet GD. Increasing HPV Vaccination
and Eliminating Barriers: Recommendations from Young Men Who Have Sex
With Men. Vaccine. 2016;34:6209-6216. doi:10.1016/j.vaccine.2016.10.075.

53.

Howard-Barr E, Moore MJ, Weiss JA, Jobli E. Public Opinion Toward Sexuality
Education: Findings Among One South Florida County. Am J Sex Educ.
2011;6(2):176-191. doi:10.1080/15546128.2011.571955.

54.

National Conference of State Legislatures. HPV Vaccine: State Legislation and
Statutes Website. http://www.ncsl.org/research/health/hpv-vaccine-statelegislation-and-statutes.aspx. Published 2017. Accessed April 2, 2018.

55.

Altman T. Senate Bill 146 (2013). Tallahassee, FL: Florida Senate; 2013.
http://www.flsenate.gov/Session/Bill/2013/146/BillText/Filed/HTML. Accessed
April 2, 2018.

56.

Rodriguez JJ. Senate Bill 1558 (2018). Tallahassee, FL: Florida Senate; 2018.
https://www.flsenate.gov/Session/Bill/2018/01558. Accessed April 2, 2018.

51

TABLES
Table 4.1. Sociodemographic Characteristics of Participants By Gender
Characteristics

Total
N=386
Mean(SD)

Female
n=264
Mean(SD)

Male
n=110
Mean(SD)

Age, y

22.4 (5.0)

22.2 (4.5)

22.6 (5.4)

n

n(%)

n(%)

Hispanic/Latino

248(64.7)

171 (63.6)

77 (67.5)

Not Hispanic/Latino

128(33.4)

95 (35.3)

34 (29.8)

Not Sure/Unknown

7(1.8)

3 (1.1)

3 (2.6)

White/Caucasian

235(62.5)

164 (62.4)

75 (66.4)

Black/African American

81(21.5)

57 (21.7)

25 (22.1)

2(0.5)

1 (0.4)

0 (0)

14(3.7)

9 (3.4)

5 (4.4)

More than one race

27(7.2)

23 (7.6)

3 (2.7)

Not Sure/Unknown

17(4.5)

12 (4.6)

5 (4.4)

Straight

248(64.9)

184 (68.1)

64 (57.1)

LGBTQ

134(35.1)

86 (31.9)

48 (42.9)

0

54(14.1)

38 (14.1)

16 (14)

1-5

214(55.8)

166 (61.7)

48 (42.1)

6-10

57(14.8)

39 (14.5)

18 (15.8)

>10

58(15.1)

26 (9.7)

32 (28.1)

Insured

238(78)

161 (75.9)

77 (82.8)

Uninsured

53(17.3)

42 (19.8)

11 (11.8)

Don't Know

14(4.6)

9 (4.2)

5 (5.4)

254(65.9)

171 (63.1)

83 (72.8)

Married

16(4.2)

12 (4.4)

4 (3.5)

Divorced/Widowed

4(1.0)

3 (1.1)

1 (0.9)

111(28.8)

85 (31.4)

26 (22.8)

Ethnicity

Race

American Indian/Alaska
Native
Asian/Pacific Islander

Sexual Orientation

Lifetime Sexual Partners

Health Insurance

Relationship status
Single

In a Relationship
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Table 4.2. Differences in HPV-Related Awareness, Perceived Knowledge, and Vaccine
Attitudes by Vaccine Initiation

Total

0 Doses HPV
Vaccine
n(%)

≥1 Dose HPV
Vaccine
n(%)

257
50

143 (77.7)
41 (22.3)

114 (92.7)
9 (7.3)

Characteristics
Heard of HPV before today
Yes
No/Don’t Know
Yes
Perceived
knowledge of
HPV
Nothing/Little
Moderate/a Lot
Perceived knowledge of
HPV vaccination
Nothing/Little
Moderate/a Lot
Vaccine attitudes
Positive
Negative

P-value
0.001

0.007
216
91

140 (76.1)
44 (23.9)

76 (61.8)
47 (38.2)
<0.001

238
68

159 (86.9)
24 (13.1)

79 (64.2)
44 (35.8)
<0.001

210
91

105 (57.7)
77 (42.3)
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105 (88.2)
14 (11.8)

FIGURES
Figure 4.1. Low Versus High Perceived Knowledge of HPV by Measured Knowledge
Score
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Figure 4.2. Low Versus High Perceived Knowledge of HPV Vaccination by Measured
Knowledge Score

55

Figure 4.3. Women’s HPV Knowledge Score, Stratified by Age Group
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CHAPTER V
Usefulness of a brief intervention in improving HPV-related knowledge and
attitudes in ethnically diverse students attending a Hispanic-Serving Institution
Abstract
Purpose: To evaluate an intervention designed to improve human papillomavirus (HPV)
and HPV vaccine awareness, knowledge, and attitudes. Design: Pre- and postintervention surveys. Setting: An urban Hispanic-Serving south Florida university.
Subjects: Three hundred eighty-seven diverse college students attending a gender studies
course. Intervention: Students received a brief educational message designed to improve
HPV-related knowledge and attitudes. Baseline and followup survey data were collected.
Measures: Outcome measures included baseline and followup awareness of HPV,
perceived knowledge of HPV and HPV vaccination, measured knowledge score, and
vaccine attitudes. Analysis: Chi square, ANCOVA, and Wilcoxon Rank-Sum tests were
used to evaluate the efficacy of the intervention. Results: Hispanic women (48%) were
more likely to have initiated HPV vaccination than Hispanic men (27%; P=0.006). At
baseline, 70% of participants scored <4/7 points in knowledge. Hispanic participants had
more positive attitudes toward HPV vaccination (62% vs. 44%; P=0.009) and were more
willing to become vaccinated (66% vs. 46%; P=0.02) than non-Hispanic participants.
Participants’ HPV knowledge improved by 41% after the intervention, with no difference
by ethnicity in post-intervention score. Conclusion: The intervention was useful in
improving HPV-related knowledge and attitudes among diverse college students. Future
studies should examine barriers to vaccination among ethnic minorities.
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Purpose
Human papillomavirus (HPV) infection is the most common sexually transmitted
infection globally, and is responsible for multiple clinical outcomes, such as genital warts
and cervical, anal, and oropharyngeal cancers.1 Three safe and effective vaccines have
been licensed to protect against HPV, and have been proven to significantly decrease
HPV-related morbidity.2 Recent data have not shown any differences in other routine
vaccine coverage rates by ethnicity; however, there is evidence that Hispanic parents are
more likely to be very concerned about vaccine safety than non-Hispanic whites.3 Despite
this, Hispanic parents are also more likely than non-Hispanic whites to follow a
healthcare provider’s recommendations and less likely to refuse a vaccine for their
children.4
Hispanics make up the largest ethnic minority group in the U.S. Florida leads the
country in number of residents of Cuban descent.5 Hispanics residing in the U.S.
generally have lower rates of cancers compared to non-Hispanic whites, apart from
cancers caused by an infectious agent, as is the case with cervical cancer and HPV. 6
Hispanic women have high rates of HPV infection and low rates of cervical cancer
screening, leading to higher incidence of cervical cancer than non-Hispanic white and
Black populations.7,8 While significant variability in cancer rates exists between
Hispanics of different countries of origins, it has been shown that unlike other Hispanic
populations, Cubans living in the U.S. have lower cervical cancer rates that are similar to
non-Hispanic whites.9 This distinct cancer profile may be due to a higher observed
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education level in comparison to Hispanics from other countries residing in Florida, and
to Cuban cervical cancer screening rates similar to the U.S.10
Despite advancements in screening, the state of Florida has one of the highest
cervical cancer death rates nationwide.11 Despite HPV being vaccine-preventable, and
clinical outcomes of infection ranging from stigmatizing to deadly, HPV-related
knowledge is reportedly low among Hispanic populations compared to non-Hispanic
whites in the U.S.12,13
HPV educational interventions have been efficaciously employed in various
settings, primarily with women and parents.14–17 However, less is known about the
potential impact of HPV education for ethnically diverse communities on knowledge and
vaccine attitudes. Recent studies have had mixed results in correlating Hispanic ethnicity
with HPV vaccine acceptability, and many of these had limited participation of Hispanic
men.18–20 None of these examined HPV vaccinations as a function of vaccine hesitancy,
which the World Health Organization defines as a “delay in acceptance or refusal of
vaccines despite availability of vaccination services”.21 Hispanic and other ethnic
minority groups should be knowledgeable about the potential risks of HPV and the
benefits that can accrue by becoming vaccinated against it. Additionally, very little is
known about HPV-related attitudes among young Hispanic residents of south Florida. In
support of the Healthy People 2020 goal to reach 80% HPV vaccine coverage, the aim of
this study was to develop and then test the efficacy of an educational intervention for
improving HPV-related knowledge and attitudes among ethnically diverse students
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enrolled in a Hispanic-Serving Institution (HSI) in south Florida, a region known to have
many Cuban and other Hispanic populations and a high incidence of cervical cancer.
Methods
Design
From April 2015 to February 2017, we conducted a brief in-class intervention in
English with students enrolled at a public, urban HSI in south Florida. The university
requires all students to speak, read, write, and understand English when enrolled. The
intervention utilized a pre-test and post-test to evaluate the efficacy of a 30-minute
educational presentation and question and answer session designed to improve basic
knowledge of HPV and HPV vaccination.
Sample
The educational intervention was targeted to an ethnically diverse purposive
sample of students enrolled at a large Hispanic-serving university situated in south
Florida. We recruited from four undergraduate gender studies courses from the spring
2015 to spring 2017 semesters. In addition, we sampled from three dietetics and public
health courses in January and February of 2017. Every member of the seven classes who
attended on the day of data collection was asked to participate (total enrollment of 409).
Participants were read a brief statement regarding voluntary participation and consent,
and students were permitted to leave the room at any point if they did not wish to
participate. Students under the age of 18 were excluded from study participation. The
university’s Institutional Review Board approved the study protocol prior to
implementation.
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Measures
The self-administered written questionnaires elicited self-perceived and measured
knowledge about HPV, as well as attitudes regarding severity, susceptibility, benefits,
and barriers related to HPV and HPV vaccination. The matched pre- and postintervention questionnaires consisted of a total of 62 items (38 in the pretest, 24 in the
posttest). It was adapted in part from the 2009 University of North Carolina Men’s Health
Survey,22, 23 with additional questions added after a review of the more recent literature.
Surveys were pre-tested in a focus group and subsequently revised.
At baseline, demographic data (i.e. age, gender identity, ethnicity/race, health
insurance status, sexual orientation, relationship status, sexual practices, and number of
partners) were collected from participants. This was followed by a single question asking
participants if they had ever heard of HPV or human papillomavirus before that day (yes,
no, don’t know). Participants then indicated how many doses of HPV vaccine they had
received as of that day (0-3, don’t know), and subsequently if they were not already fully
vaccinated, if they were willing to take the HPV vaccine (yes, no, don’t know).
Participants were then asked to describe their self-perceived knowledge of HPV and HPV
vaccines in two separate questions as “Nothing at all,” “a little,” “a moderate amount,” or
“quite a lot”.
We measured actual HPV knowledge with seven true/false items; correct scores
were totaled, and respondents were categorized as either high knowledge (four or more
questions correct) or low knowledge (three or less questions correct). Eleven questions
measured attitudes toward various HPV-related statements on a five-point Likert scale
ranging from “strongly agree” to “strongly disagree” with an additional “don’t know”
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option. All knowledge items were addressed in the educational portion of the
intervention, and further clarified if needed during the question and answer session. The
posttest included followup knowledge and attitude questions identical to the pretest with
additional questions regarding participants’ experience with the intervention.
Intervention
The intervention was designed to improve knowledge and attitudes regarding
HPV and HPV vaccination. It was piloted in its entirety in April 2015. The intervention
took from 40-50 minutes to complete and consisted of a pretest, moderated educational
presentation, question and answer session, and an immediate posttest.
Pre- and post-questionnaires were distributed before delivery of the intervention,
matched by identical numerical identifiers. Each survey took approximately 5-10 minutes
to complete, and was collected immediately upon completion. The evidence-based
presentation contained 26 PowerPoint slides and introduced general information about
HPV, including virus subtypes, transmission, clinical outcomes, diagnosis, treatments,
prognosis, and vaccination/prevention options. Presentation messages were tailored for
ethnically diverse young adults by incorporating physical Hispanic representation in
intervention materials.24 This was intended to develop “felt targetedness” among
participants, an important construct in health marketing that identifies the feeling of being
the intentional recipient of the health information.25,26 The question and answer sessions
were approximately ten minutes long, and allowed students to ask more specific, often
situational questions, although many times the questions were meant to confirm
information already presented. Students received tokens of appreciation at the end of data
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collection, such as pens, pencils, lip balm, and condoms sponsored by the university’s
student health center.
Analysis
We report percentages for the complete sample, and percentages (n/N) when
analyses contain missing data. Univariate frequencies were calculated for demographic
variables in the entire sample, and then stratified by ethnicity (Hispanic versus nonHispanic). Survey questions were collapsed into dichotomous outcomes where
appropriate. Attitude items were coded such that “strongly agree” or “agree”
corresponded to a positive attitude toward that topic. Pearson’s Chi-Square or Fisher’s
exact tests were performed to determine differences between and among Hispanic/NonHispanic groups. Wilcoxon rank-sum tests characterized pre- versus post-intervention
results. In addition, mean knowledge change from pre-test to post-test was evaluated with
paired sample t tests and one-way ANCOVA. Statistical significance was set at P<0.05.
Reliability assessment of the knowledge score was conducted using Cronbach’s alpha.
All analyses were performed using Statistical Package for the Social Sciences (version
22.0).
Results
Descriptive Analyses
Of the 409 students consenting to participate, two were under the age of 18 and
excluded from the study. Three hundred ninety-seven participants submitted postintervention surveys (98%), seven of which did not include baseline data and were
excluded. Of these, 382 reported an ethnic identity and were included in the current
analysis. Participants were mostly female (71%), with an average age of 22 years
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(SD=5.1). Over half were Hispanic (66%), white (61%), and single (66%). The majority
identified their orientation as heterosexual or straight (64%). Most had already initiated
some form of sexual activity (83%) and had between one and five lifetime sexual partners
(56%) at the time of survey. Most reported having insurance coverage (78%). No
statistical differences were evident between Hispanic and non-Hispanic participants
regarding age, gender, sexual orientation, lifetime sexual experiences, relationship status,
or insurance status (Table 1).
Baseline
Awareness and Knowledge
Hispanic participants (86%) were more likely than non-Hispanic participants
(78%) to have heard of HPV prior to the intervention (P=0.05). Non-Hispanic (63%)
participants were more likely than Hispanic participants (54%) to report receiving at least
some information about HPV prior to the intervention, although this difference was not
significant at the 95% confidence level (P=0.06).
Twenty-one percent of Hispanic males had never heard of HPV before the
intervention experience and 58% reported receiving no information about HPV (similar
to non-Hispanic men) compared with 41% of Hispanic women (P=0.02). When asked
“How much would you say you know about HPV?” about a third of Hispanic and nonHispanic participants described their knowledge as “moderate” or “a lot”. Regarding
HPV vaccination, 32% of participants reported moderate to high self-perceived
knowledge. At baseline, 70% of all participants received low scores (<4/7) on HPV
knowledge, with no difference by ethnicity.
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Vaccine Uptake
While 41% of respondents reported receiving at least one dose of HPV vaccine,
only 20% of respondents had received three doses (Figure 1). Forty-one percent of
Hispanic participants reported having one or more doses of HPV vaccine, a similar
percentage as non-Hispanic participants (39%, P>0.05). Hispanic women (48%) were
more likely than Hispanic men (27%) to have received at least one dose of HPV vaccine
(P=0.006), but non-Hispanic men and women were equally likely to report receiving at
least one dose (P>0.05).
Vaccine Attitudes
Regardless of ethnicity, 69% of participants reported that HPV was a serious
concern for women, while only 47% reported that HPV was a serious concern for men.
Hispanic men were significantly more likely than Hispanic women to be unsure regarding
many of the attitude questions. Fifty-seven percent of Hispanic men reported being
unsure if HPV was a rare infection. Despite this, 39% percent of Hispanic men were
unsure if HPV was a serious concern for women, while 49% were unsure about the threat
to men.
The majority of participants (72%) reported positive attitudes toward general
vaccine safety and effectiveness. Hispanic students (62%) were more likely to have a
positive opinion at baseline of the HPV vaccine (versus 44%, P=0.009), and more likely
(66%) than non-Hispanic students (46%) to be willing to take the HPV vaccine if not
already vaccinated (P=0.02). Hispanic students were more likely than non-Hispanic
students to report that women (74% versus 62%, P=0.04), and to a lesser extent, men
(68% versus 58%, P=0.04) should be vaccinated against HPV. Twelve percent of
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participants who agreed that women should be vaccinated against HPV disagreed or were
unsure if men should be vaccinated. Two-thirds of Hispanic participants (67%) agreed
with the statement “everyone should be vaccinated against HPV” compared with 55% of
non-Hispanic participants (P=0.04). Non-Hispanic men (37%) were less likely to believe
that everyone should be vaccinated against HPV than non-Hispanic women (61%,
P=0.03).
Post-Intervention
Knowledge
Immediately after the intervention, participants showed a statistically significant
improvement in knowledge and attitudes toward HPV and vaccination. When asked again
about their self-perceived knowledge of HPV, 94% of those who felt limited knowledge
at baseline felt they knew more following the intervention. Similarly, 91% felt
more knowledgeable about the HPV vaccines following the intervention. Participants
improved their average knowledge score from 2.4 points (SD=2.0) to 5.3 (SD=1.5) out of
seven (P<0.001). There was no difference in post-intervention knowledge score between
ethnicities after means were adjusted for pre-intervention score F(1, 349)=.276, P=.60.
Further stratification by gender showed that men, regardless of ethnicity, performed just
as well as women on the post-test despite earning slightly lower baseline knowledge
scores (Fig. 2). Individual item analysis showed that participants significantly improved
in each knowledge measure except one. At post-test 46% of participants still incorrectly
answered that herpes was caused by HPV, despite this being an improvement from 83%
incorrect at baseline.
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Vaccine Attitudes
Consideration of HPV as a serious concern for women increased from 69% at
baseline to 92% (Z=-10.2, P<0.001), and from 47% to 86% for men (Z=-8.2, P<0.001).
Despite this, only 63% of women and 73.6% of men felt HPV was a threat to their own
health. Hispanic participants were still more likely than non-Hispanic participants to
agree that women (93% versus 86%, respectively; P=0.05) and men (92% versus 86%,
respectively; P=0.05) should be vaccinated against HPV.
Attitudes toward general vaccine safety and effectiveness moderately increased
following the intervention (from 72% in pre-test to 81%). Opinions of the HPV vaccine
improved overall at followup, with non-Hispanic attitudes improving to 73%, yet not
enough to close the significant attitude gaps seen at baseline compared to Hispanic
participants (81%, P=0.04).
Intervention Evaluation
No differences were found in evaluating components of the intervention. Both
Hispanic and non-Hispanic participants found the intervention experience to be highly
acceptable; 93% rated the overall intervention experience to be “positive” or “very
positive”. When assessing each component of the intervention, 96% of participants found
the educational presentation to be an appropriate length. Ninety-eight percent felt the
question and answer session that followed the educational portion to be useful, and 97%
felt they learned a great deal from their participation.
Discussion
College students aged 18-26 are in a unique position to participate in catch-up
HPV vaccination and should be educated on HPV and vaccination options. A brief HPV
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educational intervention administered to ethnically diverse, undervaccinated young adults
can potentially improve vaccination rates. HPV knowledge and attitudes can significantly
be altered; gender and ethnic disparities can be dramatically reduced.
Baseline knowledge of HPV and HPV vaccination was equally low in our sample
of undergraduate students. Women had similar baseline knowledge of HPV and HPV
vaccination as their male counterparts, which was a surprising finding, given that the
vaccine was initially intended and marketed for women and girls.27 Several studies to find
women surpassing men in HPV-related knowledge.28,29 Vaccine initiation (≥1 dose) in
Hispanic students was 41%, similar to non-Hispanics in this sample, despite reporting
receiving less HPV-related information prior to involvement in the intervention. Hispanic
adolescents surveyed in a 2015 Florida study reported 61.7% of women and 50.1% of
men having received at least one dose of HPV vaccine., 30 a higher coverage than
observed in our study. Results at our university fall well below national HPV vaccine
coverage of 63% for adolescent women, and far below the 80% coverage rate needed to
see real reductions in the medical burden of HPV.
Despite finding similar rates of vaccine initiation in Hispanic and non-Hispanic
participants in our study, there were significant differences in the way Hispanic
participants viewed HPV vaccination compared to non-Hispanic participants, which
extended into differences in willingness to become vaccinated in the future. Several
studies describe Hispanic vaccine consumers as being wary of side effects, 3,4 though we
found Hispanic students to have more positive views of HPV vaccination. This may be
explained by a burgeoning hesitancy to vaccines among non-Hispanic whites, who rely
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less on the medical opinions of doctors than Hispanics to help them make vaccination
decisions.31
Hispanic participants were more likely to believe that HPV is a serious concern,
and expressed more willingness to become vaccinated if not already. Hispanic
participants also reported receiving less information on the topic of HPV and HPV
vaccination, even with similar insurance coverage as non-Hispanic participants. In
addition, Hispanic participants had more positive views of the safety and effectiveness of
vaccination in general. These observations suggest that Hispanic students would have
higher vaccine coverage than non-Hispanic students if they were provided with the
amount of information that non-Hispanic students reported receiving before the
intervention. Nevertheless, Hispanic positive attitudes toward vaccination in general as
well as toward HPV vaccine may not be enough to influence vaccine coverage rates
among Hispanics in Florida and can be greatly improved.
There were several limitations in this study. It was conducted at a single HSI with
students enrolled in a limited number of classes. Enrolled students may not be
representative of the community or the population of college students in south Florida.
Results of this study should not be generalized to other universities or the south Florida
community without due caution. We recruited from a region known to have a large
Cuban population; while identifying themselves primarily as Hispanic, we cannot
generalize our findings to non-Cuban Hispanic populations due to sociodemographic and
other differences between Cubans and other Hispanic nationalities. Our assessments were
conducted at baseline and immediately post-intervention, so sustainable changes in
knowledge, favorable attitudes, and vaccine acceptance were not determined. Vaccination
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status was not assessed again in the weeks after the intervention, so we were unable to
make any claims that the intervention prompted undervaccinated participants to become
vaccinated.
Comparison groups could be utilized in future studies to determine the
comparative efficacy of a brief educational intervention to other prevention strategies.
Future studies assessing the role of education on HPV knowledge and attitudes should
include more measures on ethnicity and pre-existing vaccination stances so that factors
related to vaccine intentions can be thoroughly assessed. Providers should prioritize
young adults during routine health screenings, and work to minimize missed
opportunities for vaccination in a culturally competent and inclusive manner. Particular
care should be taken to tailor HPV educational messages for Hispanic young men and
women in both clinical and non-clinical settings.
Conclusions
HPV-related knowledge and attitudes can be improved through a brief, tailored
and culturally competent educational intervention experience in a college setting.
Differences between Hispanic and non-Hispanic students at baseline disappeared at
posttest, suggesting that culturally tailored educational materials are a meaningful method
for addressing knowledge disparities in ethnic minority communities. Our findings also
highlight the ongoing implications of vaccine-hesitant attitudes, despite the proven safety
and effectiveness of HPV vaccines. While our approach was successful in bridging a gap
for participants with vaccine-hesitant attitudes, more comprehensive strategies might be
needed in the future to reach 80% HPV vaccination rates nationwide.

70

References
1.

Centers for Disease Control and Prevention. 2015 STD Treatment Guidelines.
MMWR Recomm Rep. 2015;64(RR-3):1-137.
https://www.cdc.gov/std/tg2015/toc.htm. Accessed April 26, 2018.

2.

Petrosky E, Bocchini J, Hariri S, et al. Use of 9-Valent Human Papillomavirus
(HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory
Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep.
2015;64(11);300-304.
https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a3.htm. Accessed
August 8, 2017.

3.

Shui IM, Weintraub ES, Gust DA. Parents Concerned About Vaccine Safety:
Differences in Race/Ethnicity and Attitudes. Am J Prev Med. 2006;31(3):244-251.
doi:10.1016/J.AMEPRE.2006.04.006.

4.

Freed GL, Clark SJ, Butchart AT, Singer DC, Davis MM. Parental Vaccine Safety
Concerns in 2009. Pediatrics. 2010;125(4):654-659. doi:10.1542/peds.2009-1962.

5.

Ennis SR, Ríos-Vargas M, Albert NG. The Hispanic Population: 2010. In: 2010
Census Briefs. U.S. Department of Commerce. Economics and Statistics
Administration. United States Census Bureau. 2011.
https://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf. Accessed November
30, 2017.

6.

Siegel R, Naishadham D, Jemal A. Cancer Statistics for Hispanics/Latinos, 2012.
CA Cancer J Clin. 2012;62(5):283-298. doi:10.3322/caac.21153.

7.

Viens LJ, Henley SJ, Watson M, et al. Human Papillomavirus–Associated Cancers
— United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2016;65(26):661666. doi:10.15585/mmwr.mm6526a1.

8.

Watson M, Saraiya M, Benard V, et al. Burden of Cervical Cancer in the United
States, 1998-2003. Cancer. 2008;113(S10):2855-2864. doi:10.1002/cncr.23756.

9.

Pinheiro PS, Sherman RL, Trapido EJ, et al. Cancer Incidence in First Generation
U.S. Hispanics: Cubans, Mexicans, Puerto Ricans, and New Latinos. Cancer
Epidemiol Biomarkers Prev. 2009;18(8):2162-2169. doi:10.1158/1055-9965.epi09-0329.

10.

Garrote LF, Sankaranarayanan R, Anta JJL, et al. An Evaluation of the Oral
Cancer Control Program in Cuba. Epidemiol. 1995;6(4):428-431.

11.

U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2014
Incidence and Mortality Web-Based Report.; 2017.

71

https://nccd.cdc.gov/uscs/cancersrankedbystate.aspx?printfriendly=1. Accessed
January 8, 2018.
12.

Bastani R, Glenn BA, Tsui J, et al. Understanding Sub-Optimal HPV Vaccine
Uptake among Ethnic Minority Girls. Cancer Epidemiol Prev Biomarkers.
2011;20:1463-1472. doi:10.1158/1055-9965.epi-11-0267

13.

Reimer RA, Schommer JA, Houlihan AE, Gerrard M. Ethnic and Gender
Differences in HPV Knowledge, Awareness, and Vaccine Acceptability Among
White and Hispanic Men and Women. J Community Health. 2014;39(2):274-284.
doi:10.1007/s10900-013-9773-y.

14.

Hopfer S. Effects of a Narrative HPV Vaccination Intervention Aimed at Reaching
College Women: A Randomized Controlled Trial. Prev Sci. 2012;13(2):173-182.
doi:10.1007/s11121-011-0254-1.

15.

Allen JD, Othus MKD, Shelton RC, et al. Parental Decision Making About the
HPV Vaccine. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2187-2198.
doi:10.1158/1055-9965.EPI-10-0217.

16.

Vanderpool RC, Cohen EL, Crosby RA, et al. “1-2-3 Pap” Intervention Improves
HPV Vaccine Series Completion Among Appalachian Women. J Commun.
2013;63(1):95-115. doi:10.1111/jcom.12001.

17.

Brawner BM, Baker JL, Voytek CD, et al. The Development of a Culturally
Relevant, Theoretically Driven HPV Prevention Intervention for Urban Adolescent
Females and Their Parents/Guardians. Health Promot Pract. 2013;14(4):624-636.
doi:10.1177/1524839912462389.

18.

Brewer NT, Fazekas KI. Predictors of HPV Vaccine Acceptability: A TheoryInformed, Systematic Review. Prev Med. 2007;45:107-114.
doi:10.1016/j.ypmed.2007.05.013.

19.

Ferris DG, Waller JL, Miller J, et al. Variables Associated with Human
Papillomavirus (HPV) Vaccine Acceptance by Men. J Am Board Fam Med.
2009;22(1):34-42. doi:10.3122/jabfm.2009.01.080008.

20.

Colón-López V, Ortiz AP, Palefsky J. Burden of Human Papillomavirus Infection
and Related Comorbidities in Men: Implications for Research, Disease Prevention
and Health Promotion Among Hispanic Men. P R Health Sci J. 2010;29(3):232240.

21.

Report of the SAGE Working Group on Vaccine Hesitancy. 2014.
http://www.who.int/immunization/sage/meetings/2014/october/SAGE_working_gr
oup_revised_report_vaccine_hesitancy.pdf?ua=1. Accessed June 27, 2018.

72

22.

Reiter PL, Brewer NT, McRee A-L, Gilbert P, Smith JS. Acceptability of HPV
Vaccine Among a National Sample of Gay and Bisexual Men. Sex Transm Dis.
2010;37(3):197-203. doi:10.1097/OLQ.0b013e3181bf542c.

23.

Brewer NT, Ng TW, Mcree A-L, Reiter PL. Men’s Beliefs About HPV-Related
Disease. J Behav Med. 2010;33(4):274-281. doi:10.1007/s10865-010-9251-2.

24.

Kreuter MW, McClure SM. The Role of Culture in Health Communication. Annu
Rev Public Health. 2004;25(1):439-455.
doi:10.1146/annurev.publhealth.25.101802.123000.

25.

Resnicow K, Baranowski T, Ahluwalia JS, Braithwaite RL. Cultural Sensitivity in
Public Health: Defined and Demystified. Ethn Dis. 1999;9(1):10-21.

26.

Grier SA, Kumanyika S. Targeted Marketing and Public Health. Annu Rev Public
Health. 2010;31(1):349-369. doi:10.1146/annurev.publhealth.012809.103607.

27.

Dunne E, Markowitz L, Chesson H, et al. Recommendations on the Use of
Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on
Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep.
201;60(50):1705-1708.

28.

Sandfort JR, Pleasant A. Knowledge, Attitudes, and Informational Behaviors of
College Students in Regard to the Human Papillomavirus. J Am Coll Heal.
2009;58(2):141-149.

29.

Fontenot HB, Fantasia HC, Sutherland MA, Lee-St. John T. HPV and HPV
Vaccine Information Among a National Sample of College and University
Websites. J Am Assoc Nurse Pract. 2016;28(4):218-223. doi:10.1002/23276924.12312.

30.

Centers for Disease Control and Prevention. Human papillomavirus (HPV)
vaccination coverage among adolescents 13-17 years by State, HHS Region, and
the United States, National Immunization Survey-Teen (NIS-Teen), 2015.

31.

Smith PJ, Chu SY, Barker LE. Children Who Have Received No Vaccines: Who
Are They and Where Do They Live? Pediatrics. 2004;114(1):187-195.

73

Tables
Table 5.1. Sociodemographic Characteristics of Participants by Ethnicity.

Characteristics

Age, y
Sexual Orientation
Straight
Gay/Lesbian
Bisexual
Other
Race
White
Black
Other
Lifetime Sexual
0
Partners
1-5
6-10
>10
Health Insurance
Insured
Uninsured
Don't Know
Relationship status
Single
Married
In a Relationship
Divorced/Widowed

NonHispanic
n=129
Mean(SD) Mean(SD) Mean(SD)
22.4(5.0)
22.2(4.5)
22.6(5.4)
n
n(%)
n(%)
Total
N=382

Hispanic
n=252

244
66
53
16

154(61.4)
48(19.1)
36(14.3)
13(5.2)

90(70.3)
18(14.1)
17(13.3)
3(2.3)

233
82
67

197(77.9)
15(5.9)
41(16.2)

36(27.9)
67(51.9)
26(20.2)

54
214
55
57

36(14.3)
150(59.8)
32(12.7)
33(13.1)

18(14)
64(49.6)
23(17.8)
24(18.6)

234
52
15

158(79.4)
30(15.1)
11(5.5)

76(74.5)
22(21.6)
4(3.9)

254
16
4
110

162(64.0)
10(4.0)
2(0.8)
79(31.2)

90(69.8)
6(4.7)
2(1.6)
31(24.0)
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Figures
Figure 5.1. HPV Vaccine Initiation and Completion Rates by Gender and Ethnicity.
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Figure 5.2. Change in Mean Knowledge Score From Baseline to Post-Intervention by
Ethnicity and Gender.
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CHAPTER VI
Impact of a brief educational HPV intervention among sexually diverse college
students
Abstract
Self-identified lesbian, gay, bisexual, transgender, or queer (LGBTQ; n=131, 43.5%) and
heterosexually-identified (HSI; n=170, 56.9%) students enrolled in gender studies
courses at a Florida university from 2015 to 2017 completed a questionnaire regarding
human papillomavirus (HPV) and HPV vaccine knowledge, attitudes, and practices.
Women who have sex with women (WSW; 88%) were just as likely as HSI women
(86%) to have heard of HPV, received any doses of HPV vaccine (42% vs 46%,
respectively), and positively view HPV vaccination (62% vs 59%, respectively); yet were
more willing to be vaccinated than HSI women (71% vs 53%; P=0.04). Similarly, men
who have sex with men (MSM, 50%) were just as likely as HSI men (41%) to believe
HPV is a serious concern for men and that men should be vaccinated (73% vs 58%;
P>0.05). Nevertheless, MSM (92%) were more likely than HSI men (68%) to have heard
of HPV, to receive any doses of HPV vaccine (37% vs 19%), positively view HPV
vaccination (58% vs 39%), and were more willing to be vaccinated (86% vs 39%;
P≤0.05). LGBTQ students have positive views towards HPV vaccination and are more
interested in becoming vaccinated than heterosexual students, but require prevention
information and education pertinent to their particular health needs. Opportunities to
engage, educate, and vaccinate sexual minority young adults should be capitalized upon.
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Introduction
High-risk, oncogenic human papillomavirus (HPV) subtypes can cause cancers of
the cervix, genitals, anus, and oropharynx. Low-risk, non-oncogenic subtypes can cause
genital warts.1 Cervical cancer has prevailed for decades as the clinical paradigm for
cancer caused by HPV, with an established clinical framework for screening and
treatment in women.2 Recent evidence has established the natural history of
oropharyngeal cancers in high-risk groups, and indicates substantial biological homology
to the relationship between cervical cancer and HPV.
Although there are many acceptable terms used to refer to lesbian, gay, bisexual,
and transgender people, we will use the acronym LGBTQ (lesbian, gay, bisexual,
transgender, questioning) when collectively describing those who identify as sexual
minorities, and HSI (heterosexually-identifying) to describe those who self-identify as
heterosexuals. The terms men who have sex with men (MSM) and women who have sex
with women (WSW) will be used to describe those who self-report as sexual minority
males and females, respectively. The terms lesbian, gay, and bisexual are used when we
are able to delineate specific differences.
LGBTQ are a medically underserved, priority health group, and require specific
attention.3 The majority of school-based sexual education programs are not
comprehensive and typically omit LGBTQ sexual health topics. By the time they reach
college age (18-26 years), MSM and WSW will have already experienced a multitude of
sexual health inequities which put them at elevated risk for HPV outcomes, often
complicated by reluctance to share information about their sexual orientation with
healthcare providers.3,4 MSM in particular have higher rates of HPV infection and disease
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than HSI men; a 2016 study estimated 78% of HIV-negative MSM had anal HPV
infection and 35% of these infections were found to be cytologically abnormal, a higher
rate than HSI men’s infections.5 Positive HIV status increases the risk for anal HPV
infection among MSM. Fewer studies examined HPV-related topics among WSW, who
are at higher risk for HPV infection than HSI women.6 None were interventions. Despite
this shortcoming, a common misconception is that sexually active WSW are at less risk
due to underestimation of prior heterosexual infection, reduced likelihood to receive Pap
testing, and MSM-dominated sexual health promotion efforts.7,8 From 2003-2012, an
estimated 49.7% of WSW were infected with any HPV, compared with 41% of HSI
women, with even larger differences for oncogenic high-risk types (37.7% in WSW vs.
28.2% in HSI women).9 Evidence also suggests that like MSM, WSW have a higher
prevalence of oral HPV infection than HSI women.10
The 9-valent vaccine against HPV is recommended in the U.S. to prevent genital
warts and HPV-related cancers, including cervical and oropharyngeal. 11 The Advisory
Committee on Immunization Practices (ACIP) currently recommends routinely
vaccinating 9-14-year-old children on a 2-dose schedule, regardless of gender, and
providing catch-up vaccination for women until ages 21-26. Men should receive catch-up
vaccination until age 21. For MSM, the ACIP recommends routine HPV vaccination
through age 26. Bisexual women have a higher odds of vaccine initiation and completion
than lesbian and HSI women.4,12 Gay men have higher odds than HSI and bisexual men,12
with an estimated 21% of MSM and 45% of WSW receiving at least one dose. 13,14
Several affiliations strongly advocate for HPV vaccination to be established as a national
priority.15,16 They suggest that advancement of research on effective HPV educational
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interventions be conducted. Two recent systematic reviews of interventions to increase
vaccine uptake found no interventions tailored for LGBTQ college students.17,18 Future
HPV interventions should emphasize cultural competence to influence HPV vaccine
uptake among diverse groups.
Positive HPV vaccine attitudes are a predictor of vaccine uptake, along with
provider recommendation and older age.13,19 Most studies find LGBTQ young adults to
be lacking in knowledge.20,21 Here we report on a brief, tailored intervention designed to
educate sexually diverse college students about HPV and promote HPV vaccination as a
safe and effective means of prevention. We describe immediate effects on HPV-related
awareness, knowledge, and attitudes, as well as the acceptability of the intervention in a
sexually diverse sample.
Methods
The educational intervention was designed to improve knowledge and attitudes
regarding HPV and HPV vaccination. The project was piloted in its entirety in April
2015. The project took from 30-45 minutes to complete, including a pretest, moderated
educational presentation, question and answer session, and an immediate posttest. The
self-administered written pre-/post-tests elicited self-perceived and measured knowledge
about HPV, as well as attitudes regarding severity, susceptibility, benefits, and barriers
related to HPV and HPV vaccination.
We recruited during four semesters of an undergraduate gender studies course
from the spring 2015 to spring 2017 semesters. In addition, we recruited from three
undergraduate dietetics and public health courses in January and February of 2017. Every
member of the seven classes who attended on the day of data collection was asked to
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participate (total enrollment=409 students) and was provided with a statement regarding
consent. Students under the age of 18 were excluded from study participation. The
university’s Institutional Review Board approved the study protocol prior to
implementation.
The matched pre- and post-questionnaires consisted of a total of 62 items (38
pretest, 24 posttest). It was adapted in March 2015 from the 2009 University of North
Carolina Men’s Health Survey (100 items),22,23 with additional questions derived from a
review of relevant scientific literature, using constructs of the Health Belief and
Transtheoretical Models as a theoretical guide. Questionnaires were pre-tested in a focus
group of seven graduate public health students and was subsequently revised. Pretests
and posttests were matched by numerical identifiers. No personal identifying information
was requested or recorded.
Each questionnaire took approximately 5-10 minutes to complete. At baseline, we
asked participants to self-report information about their sociodemographic characteristics
(age, gender identity, ethnicity/race, health insurance status, sexual orientation,
relationship status, sexual practices, number of partners), awareness of HPV, HPV
vaccine experiences, and willingness to become vaccinated if not already completely
protected. Participants were then asked to rate their self-perceived knowledge of HPV
and HPV vaccines. Eleven questions (six from UNC Men’s Health Survey, five adapted
from the literature) measured attitudes toward various HPV-related statements on a fivepoint Likert scale ranging from “strongly agree” to “strongly disagree” with an additional
“don’t know” option. We measured actual HPV knowledge with seven true/false items,
four of which were adapted from UNC’s Men’s Health Survey.
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Following the baseline questionnaire, the evidence-based presentation contained
26 PowerPoint images and messages that introduced general information about HPV,
including subtypes, transmission, infection outcomes, diagnosis, treatments, prognosis,
and vaccination/prevention options. The educational presentation was tailored to diverse
young adults by incorporating gender neutral and orientation-sensitive language.
LGBTQ-positive images with multicultural ethnic representation were shown. All
knowledge items assessed in the pre- and post-test questionnaire were addressed in the
presentation. The question and answer sessions immediately followed the presentation,
usually lasted about ten minutes, and allowed students to ask more specific, often
situational questions. The participants then completed the posttest, which included
followup knowledge and attitude questions identical to the pretest with additional
questions regarding participants’ experience with the intervention. Students received
tokens of appreciation such as pens, pencils, lip balm, and condoms.
Analysis
All analyses were performed using Statistical Package for the Social Sciences
(version 22.0).24 Statistical significance was set at P<0.05. Reliability assessment of the
pre and post knowledge score and attitude scales were conducted using Cronbach’s alpha.
We report percentages for the complete sample, and percentages (n/N) when analyses
contain missing data. Univariate frequencies were calculated for sociodemographic
variables in the entire sample, and then examined by self-reported gender and orientation
(LGBTQ versus HSI) to determine if there were differences between groups. Responses
were collapsed into dichotomous outcomes where appropriate. Attitude items were coded
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such that “strongly agree” or “agree” corresponded to a positive attitude toward that
topic.
Pearson’s Chi-Square or Fisher’s exact tests were performed to determine
differences between and among LGBTQ and HSI groups for categorical items. We
calculated the mean knowledge score at baseline and followup, and performed one-way
ANOVA with Tukey’s post-hoc analysis to determine if baseline mean scores differed by
binomial orientation.25,26 Differences between groups in baseline attitude score was
analyzed with Mann-Whitney-Wilcoxon test by gender.27,28 Participants who responded
“don’t know” to baseline knowledge questions were further examined with a
nonparametric binomial test to determine how they responded following the
intervention.29 Intervention effects on knowledge and attitude were tested using a
repeated measures ANOVA with Greenhouse-Geisser correction, with partial eta squared
measuring effect size of the intervention.30,31 Post-hoc Tukey tests determined if the mean
change in scores differed by orientation groups.
Results
Of the 409 students enrolled in the seven classes, 390 (95%) completed the
baseline questionnaire, and 364 (89%) completed both a baseline and a posttest
questionnaire and answered the two questions regarding self-identified gender and sexual
orientation. Most participants (n=232, 64%) self-identified as heterosexual, 132 (36%)
identified as LGBTQ. LGBTQ were more likely to be enrolled in the gender studies class
(43%) than in the Dietetics and Nutrition classes (1%). Participants had a mean age of
22.5 years (SD=5.16), and identified mostly as female (70.8%). Approximately twothirds were Hispanic (66.7%) and single (65.9%). Over half identified their race as white
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(61.0%). Over half (57%) reported between one and five lifetime sexual partners at the
time of survey. Fifty-three (15%) reported having no lifetime sexual partners. Students
reported ever having more oral (82.9%) and vaginal (71.7%) lifetime sexual experience
than anal sex experience (36.5%). Over three-fourths reported having health insurance
coverage (78.9%; Table 1).
LGBTQ students were similar to HSI students regarding age, race and ethnicity,
and insurance status, (P>0.05). LGBTQ (89%) were just as likely as straight students
(83%) to have heard of HPV and to have received at least one dose of HPV vaccine (40%
vs 42%, respectively). Almost half (46%) of LGBTQ students did not know their HPV
vaccination status compared with 35% of straight students (NS). Despite this, LGBTQ
students were more likely to have positive attitudes toward HPV vaccination (77% vs
66%; P=0.03). In addition, LGBTQ students were more willing to receive the HPV
vaccine (79% vs 58%, respectively; P=0.02), and more likely to believe men should be
vaccinated (75% vs 57%, respectively; P=0.002).
Men’s HPV Awareness and Vaccine Uptake
MSM were more likely to report greater than ten lifetime sexual partners than HSI
men (37% vs 18%, respectively, P=0.047). Regarding awareness of HPV, 92% of MSM
had heard of HPV compared to 74% of HSI men (P=0.03). HSI men (39%) were more
likely to have received zero doses of HPV vaccine than MSM (15%, P=0.035; Figure 1).
HSI men (70%) were more likely than any other orientation group (average of 45%) to
report receiving little to no information about HPV prior to the intervention experience
(P=0.001; Table 2). At baseline, MSM were more willing than HSI men to become
vaccinated against HPV if not already (85% vs. 40%, respectively; P=0.001), despite no

84

differences being reported between the two groups regarding insurance coverage.
Men’s Knowledge and Attitudes
At baseline, men’s mean knowledge score differed significantly by orientation
(F(2,106)=5.32, P=0.006), with HSI men scoring lower than gay men (P=0.005). There
was no significant difference in mean baseline score between bisexual men and HSI or
gay men (P>0.35; Figure 3). Men’s mean HPV knowledge scores significantly increased
following the intervention (Wilk’s Lambda=0.34, F(2, 95)=184.7, P<0.001, partial eta
squared= 0.66). Gay men’s mean score change from baseline to post-test was
significantly larger than HSI men (Tukey’s HSD, P=0.03; Table 3).
Regarding the HPV vaccine attitudes scale, we found that although MSM reported
more positive views than HSI men at baseline, the differences in distributions of median
scores did not differ significantly at baseline (U=418.5, Z=-1.76, P=0.08) or post-test
(U=652.5, Z=-0.76, P=0.45; Figure 4). Individual item analysis, however, showed that
baseline differences lay with certain questions. MSM were more likely than HSI men to
have a positive opinion of HPV vaccination (70% versus 44%, P=0.03), and think
everyone should be vaccinated against HPV (83% versus 61%, P=0.02), despite 70-72%
of both groups having positive views of vaccines in general. At post-test, there remained
a significant difference in their opinion of HPV vaccination, with MSM men (88%) still
more likely to have a positive opinion than HSI men (67%, P=0.03). Men’s attitudes
improved significantly following the intervention, with no differences by sexual
orientation (Wilk’s Lambda=0.34, F(1, 54)=106.6, P=0.00, partial eta squared= 0.66).
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Women’s HPV Awareness and Vaccine Uptake
Women of all orientations reported similar numbers of sexual partners (59-63%
reported 1-5 partners). WSW (88%) were just as likely as HSI women (86%) to have
heard of HPV, received any doses of HPV vaccine (42% vs 46%, respectively), but
expressed more willingness to be vaccinated (71% vs 53%; P=0.04).
Women’s Knowledge and Attitudes
Baseline knowledge score differed significantly between women’s orientation
groups (F(2,250)=4.19, P=0.016). Specifically, lesbian and bisexual women’s baseline
mean scores significantly differed (Tukey’s HSD, P=0.01). Bisexual women scored the
highest on baseline HPV knowledge with an average of 45% correct, followed by HSI
(39%) then lesbian women (28%). From baseline to post-test, women’s overall mean
HPV knowledge score increased (Wilk’s Lambda=0.37, F(1, 241)=411.56, P=0.00,
partial eta squared= 0.63), with no differences in knowledge score mean change between
HSI, lesbian, and bisexual women (P≥0.09; Figure 5).
In response to the HPV vaccine attitudes scale, WSW and HSI women had similar
scores at baseline (28/40 points; U=1696.5, Z=-1.87, P=0.06). Women’s mean change in
attitude score shifted significantly in a positive direction following the intervention
(Wilk’s Lambda=0.53, F(1, 132)=118.1, P<0.001, partial eta squared= 0.47; Figure 6).
Bisexual women’s mean change was significantly larger than HSI women’s (Tukey’s
HSD, P=0.01), with no significant difference between HSI and lesbian or bisexual and
lesbian women (P≥0.2; Table 3).
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Intervention Evaluation
At post-intervention reassessment, participants also rated the intervention and its
key components. Regarding the overall intervention experience, 93% of all participants
rated the intervention experience “positive” or “very positive.” Participants (97%) felt
they learned much from the educational presentation, and 95% found the presentation to
be an appropriate length when given the choice between that or “too long” or “too short”.
Almost all (98%) participants found the questions and answer session “helpful” or “very
helpful”. Subgroup analyses yielded no differences by gender or sexual orientation in the
evaluation of the intervention elements.
Discussion
As serious HPV-related outcomes become more commonplace, especially among
LGBTQ, we must determine the impact of HPV education in risk-reduction and
prevention on sexually diverse intervention participants. Governmental and nongovernmental health organizations are increasingly calling for efficacious interventions to
address a myriad of factors related to HPV prevention16,32–34 amidst troublingly low HPV
vaccination coverage. Few established interventions focus on the impact of participation
on the LGBTQ community. Fewer still focus on adolescent or young adult LGBTQ, and
not one has targeted the WSW community.35,36
We developed and evaluated the acceptability and efficacy of a brief HPV
educational intervention designed to inform and encourage HPV vaccination among
diverse college students. Young adults who were exposed to the intervention showed
immediate knowledge and attitude improvements. Our pre-post intervention design
evaluated two specific intervention outcomes between groups. The largest effect sizes
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were in knowledge of HPV. We found smaller, yet still significant effects in attitudinal
measures regarding general and HPV vaccine acceptability and perceived threat of HPV.
In addition to overall intervention efficacy, we found significant between group
differences by sexual orientation. HSI men in our sample reported receiving less
information about HPV than MSM prior to the intervention and reported lower levels of
HPV knowledge and less positive vaccine attitudes at baseline. At followup evaluation,
HSI men reported significantly lower gains in knowledge than MSM. This finding is
consistent with research on multidimensional education programs, which find more
reliable immediate effects on knowledge than on attitudinal measures.37,38 Whereas HPV
knowledge improved immediately after information is provided, changes in strong
attitudes toward vaccination may require larger intervention doses to permanently affect
outcomes, despite knowledge being an important determinant in attitude formation and
subsequent vaccine intentions and behaviors.
Our findings among men agree with previous investigations into HPV knowledge
and with the few HPV interventions targeting MSM. Prior to the recommendation for
men to also become vaccinated against HPV in 2011, Gerend et al. found that HSI men
were resistant to messages regarding partner protection against HPV, with intervention
treatment participants reporting similar acceptability of the HPV vaccine to the control
group.39 McRee et al. documented relatively high HPV knowledge among MSM.
However, they did not have an HSI comparison group. 36 Young MSM in their 2016
online intervention were over twice as likely as the control group to initiate HPV
vaccination. Our findings suggest that HSI may not see HPV as a serious threat.
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Conversely, we found that lesbian women had the lowest mean knowledge score
among women (but still higher than that of HSI men), and the lowest mean HPV attitude
score of all the groups regardless of gender. Bisexual women had more positive attitudes
toward HPV vaccination, and bisexual women also had the highest knowledge at baseline
among all groups. Women in our study were more likely to identify as bisexual than men.
This is supported by national datasets in which women have a greater probability than
men of being bisexual, whereas men are more likely to report being either heterosexual or
homosexual.40 Our study indicates that bisexual women are above average in HPV
knowledge and willingness to become vaccinated, despite being just as likely as HSI and
lesbian women to have heard of HPV and initiate vaccination. This is reflected in
previous studies assessing HPV vaccine uptake among WSW,4 with lesbian women
tending to be less prevention-oriented in their health behaviors due to misconceptions
about risk.
We found no interventions tailored specifically for WSW, despite their
designation as a special health population.41 This indicates that WSW are not prioritized
in HPV prevention, though lesbians tend to manifest multiple sexual health risk
indicators, such as lack of knowledge and lower likelihood of pap testing or HPV
vaccination.4,8,14 Lesbian women, who are continually left out of sexual health education
and prevention messaging,6 displayed high potential for knowledge retention and positive
attitudinal change as seen at post-intervention assessment. This could be attributed to the
LGBTQ-inclusive material presented to the participants. Despite receiving low
knowledge scores, lesbian women reported being just as frequently vaccinated as HSI
women, suggesting lesbian women either face barriers in health seeking behaviors, or are
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systematically overlooked in HPV education and prevention.42 The socially-accepted idea
that HPV as transmitted only via penetrative sex acts (involving a penis) conflates sexual
orientation and risk. This inaccuracy suggests that sexually active heterosexuals and
MSM are exclusively at risk, and is problematic for preventive efforts among WSW.
Tailored HPV education targeting sexually diverse college students is not only
efficacious but also wanted and needed. Participant attitudes toward the in-class
educational intervention experience were very positive. Ratings of each component of the
intervention were very high, with no differences by gender or sexual orientation.
Limitations
The positive results of this initial outcome evaluation indicate that the
intervention should be evaluated more rigorously in a multicenter randomized controlled
trial. In lieu of a control group, we assessed change with a pre-post design. Postintervention outcomes were assessed immediately after exposure to the intervention. As
such, it is possible that improvements in HPV knowledge and especially attitude could
regress over time as we use only one brief session to deliver the intervention. Future
studies should employ a third evaluation to characterize effects over a longer follow-up
period. Finally, we relied on participants’ self-reported knowledge and attitudes, which is
subject to recall, response, and social desirability bias. Utilizing a brief intervention
methodology, it was not possible to include behavioral outcomes such as initiation or
completion of HPV vaccination. Future studies should assess intention to vaccinate or
HPV vaccination behaviors as an outcome of the intervention and explore knowledge and
attitude as correlates of behavioral intentions and subsequent vaccine uptake.
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Conclusion
LGBTQ students have positive views towards HPV vaccination and are interested
in becoming vaccinated, but require prevention information and education pertinent to
their health needs. Opportunities to engage, educate, and vaccinate sexual minority young
adults should be capitalized upon while still prioritizing HSI men as a group in need of
intensive and reinforced HPV education.
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Tables
Table 6.1. Participant Soiciodemographic Characteristics by Orientation.
Male
Variable
Age (Mean, SD)
Race/Ethnicity
Non-Hispanic
White
Hispanic
Black

Female

HSI
(n=64)

Gay
(n=34)

Bisexual
(n=11)

24(6.7)

21(2.1)

20(1.0)

Married
Divorced/widowed
In a relationship

Uninsured
Don’t Know
Lifetime Sex
Partners
0

23(5.0)

Lesbian
(n=31)

Bisexual
(n=42)

22(3.3)

21(3.6)

Pvalue

0.14

9(14.5)

2(6.3)

--

16(9.5)

2(7.1)

4(11.1)

37(59.7)

27(84.4)

9(81.8)

116(68.6)

20(71.4)

25(69.4)

16(25.8)

3(9.4)

2(18.2)

37(21.9)

6(21.4)

7(19.4)

45(70.3)

26(76.5)

8(72.7)

109(67.7)

19(61.3)

30(71)

3(4.7)

1(2.9)

--

10(6.2)

--

2(5)

1(1.6)

--

--

30(18.6)

--

--

15(23.4)

7(20.6)

3(27.2)

12(7.5)

12(38.7)

10(24)

0.9

Insurance Status
Insured

HSI
(n=184)

0.07

Relationship Status
Single

Pvalue

0.33

0.07

0.21

42(79.2)

22(84.6)

9(34.6)

117(78)

16(84)

20(69)

10(18.9)

0(0)

1(3.8)

29(19)

3(16)

7(24)

1(1.9)

4(15.4)

0(0)

5(3)

--

2(7)

0.003

0.1

11(17.2)

3(8.8)

--

26(14)

2(7)

5(39)

1-5

30(46.9)

13(38.2)

3(27.3)

115(64)

20(65)

5(39)

6-10

9(14.1)

4(11.8)

5(14.7)

23(13)

26(62)

1(8)

>10

14(21.9)

14(41.2)

3(8.8)

17(9)

5(39)

2(15)

Vaginal Sex
Experience

44(69)

5(16)

7(70)

<0.001

150(82)

27(87)

33(79)

0.22

Oral Sex Experience

50 (79)

30(88)

10(100)

0.005

147(82)

29(94)

37(88)

0.05

Anal Sex Experience

12(20)

29(85)

10(91)

<0.001

55(32)

8(30)

2(17)

0.62
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Table 6.2. Item-Wise Post-Test Response of Participants Who Responded "Don't Know"
at Baseline.

Item

n(%) Don’t
Know baseline

Post-Test Response n(%)
Correct

Incorrect

P-value

Q1.HPV infection is rare
Q2. HPV causes herpes
Q3. AIDS is caused by HPV

167(43.6)
218(58.3)
191(50)

136(96%)
114(57%)
132(75%)

5(4%)
86(43%)
43(25%)

0.00
0.06
0.00

Q4. The only way to protect
yourself from HPV is to use
a condom

142(37.2)

121(92%)

10(8%)

0.00

Q5. Some strains of HPV are
harmless

223(58.4)

164(80)

40(20)

0.00

Q6. HPV infection can cause
cancer

193(50.7)

169(95%)

9(5%)

0.00

Q7. Student Health Services
offers HPV vaccination

284(74.9)

225(96%)

9(4%)

0.00

*nonparametric Binomial
test
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Table 6.3. Baseline and Post-Intervention Outcome Mean Scores by Sexual Orientation
Group.

Male
HSI
Gay
Bisexual
Female
HSI
Lesbian
Bisexual

Knowledge
M(SD)
Baseline
Followup

Attitude
M(SD)
Baseline
Followup

0.24(0.25) 0.81(0.16)
0.43(0.30) 0.89(0.12)
0.36(0.35) 0.79(0.19)

27(4.72) 34.3(5.32)
27.9(4.78) 36.8(4.15)
29.8(2.39) 36.8(1.9)

0.39(0.27) 0.86(0.15)
0.27(0.27) 0.85(0.13)
0.45(0.26) 0.85(0.13)

27.5(3.78) 34.2(4.58)
26.3(4.31) 35.8(4.75)
30.4(4.01) 36.9(2.98)
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Figures
Figure 6.1. Women’s HPV Vaccine Uptake by Orientation.
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Figure 6.2. Men’s HPV Vaccine Uptake by Orientation.

Men's HPV Vaccine Uptake by Orientation
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Figure 6.3. Men’s Mean Knowledge Scores at Baseline and Post-Test by Orientation.

Men's Mean Knowledge Score by Sexual Orientation
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Figure 6.4. Men’s Mean Attitude Scores at Baseline and Post-Test by Orientation.

Men's Mean Attitude Score by Sexual Orientation
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Figure 6.5. Women’s Mean Knowledge Scores at Baseline and Post-Test by Orientation.

Women's Mean Knowledge Score by Sexual Orientation
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Figure 6.6. Women’s Mean Attitude Scores at Baseline and Post-Test By Orientation.

Women's Mean Attitude Score by Sexual Orientation
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CHAPTER VII
Conclusions
This chapter summarizes the study and primary research findings as delineated in
three unique manuscripts presented as Chapters IV, V, and VI. Presented here are also
discussions of the primary findings, limitations, and recommendations for future research
related to HPV in ethnically and sexually diverse young adults.
Study Summary
Despite the availability of safe and effective HPV vaccines since 2006, HPV
vaccination rates continue to be subpar in the United States. Few studies have assessed
the acceptability and efficacy of a brief educational intervention to promote HPV vaccine
uptake in college students. Furthermore, no previous study has tested an educational
intervention tailored for and targeting both ethnically and sexually diverse college
students. This study was conducted among college students in a Hispanic-serving
university in South Florida. Brief, evidence-based HPV presentations and question and
answer sessions were delivered in conjunction with pre- and post-intervention
assessments to appraise the educational intervention experience. The Health Belief Model
and the Transtheoretical Model (or Stages of Change) were used to guide the study
design, intervention content, and interpretation of the results.
The purpose was to examine differences in HPV-related awareness, knowledge,
and attitudes among diverse students both before and after exposure to a brief educational
intervention. The first study described baseline differences in HPV-related awareness,
knowledge, and attitudes between men and women enrolled in undergraduate courses.
The second and third studies evaluated the differential efficacy of the educational
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intervention in improving HPV-related awareness, knowledge, and attitudes by ethnicity
and sexual orientation.
Discussion
The first study examined baseline gender differences in HPV and HPV
vaccination awareness, perceived and actual knowledge, and attitudes. Prior to
experiencing the intervention, most participants (84%) had heard of HPV, and 70% had
favorable attitudes toward HPV vaccination, yet there were significant gaps in vaccine
uptake. Over half (55%) of women and only 28% of men had initiated the HPV vaccine
series.
Amidst generally low knowledge scores, those who reported receiving one or
more doses of an HPV vaccine perceived themselves to be knowledgeable about HPV.
The knowledge scores accurately reflected these perceptions. Attitude was positively
associated with knowledge, in addition to being significantly associated with number of
doses received among women, but not men. Although the percent of women who
initiated HPV vaccination was below the state and national averages of 58% and 60% for
young women, these percentages are still far below the desired 80% specified by the
Department of Health and Human Services.1
Disparate knowledge outcomes for young men and women are supportive of
evidence finding behavior change is more likely to occur when individuals perceive
themselves to be at risk or susceptible to the condition.2 Until recently, most men were
oblivious to HPV-related issues as they weren’t directly affected by the primary outcome
of cervical cancer, and the vaccine was intended for women only.3,4 Recently, over 40%
of new cases of HPV-associated cancers were found in men.5 Since the ACIP released
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recommendations for men to be vaccinated in 2011, men’s awareness and knowledge
regarding HPV is slowly rising, yet still falls far behind that of women. 36 Oropharyngeal
and anal cancers, which are primarily diagnosed in men, are expected to increase as cases
of cervical cancer decrease due to continued gender disparities in HPV knowledge and
vaccination.83
Few studies have assessed differences in vaccine attitudes among ethnic groups.
A climate of vaccine hesitancy continues to grow in the United States, and there is
limited evidence of intervention efficacy in changing such attitudes.84 The second study
evaluated the differences in intervention effects between Hispanic and non-Hispanic
students, with special attention paid to attitudes toward the safety and effectiveness of
vaccines in general as a proxy measure of vaccine hesitancy.
At baseline, 41% of Hispanic and 39% of non-Hispanic participants reported
initiating the HPV vaccine series (NS). Hispanic participants (66% vs. 46% nonHispanic, P=0.02) were significantly more willing to become vaccinated against HPV if
not already vaccinated, and more likely to express positive attitudes toward the HPV
vaccine at baseline (62% vs. 44%, respectively; P=0.009). Hispanic men (21%) were less
likely to know their vaccination status than all others. They were also less likely to report
receiving any information about HPV (58%, P=0.02). Following the intervention,
Hispanic and non-Hispanic men and women increased their knowledge scores by an
average of almost 43%.
Hispanic and non-Hispanic participants evaluated the components of the
intervention as very positive. Nevertheless, non-Hispanic students showed less favorable
attitudes towards HPV vaccination following the intervention (86% vs >92% in Hispanic
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students, P=0.04). In 10% of non-Hispanic cases (vs. 5% in Hispanic cases), participant
attitudes were even more negative post-intervention than at baseline, indicating the
intervention may have reinforced existing vaccine-hesitant attitudes among some students
instead of counteracting them.
Contradictory of early findings that Hispanics are wary of vaccine safety
regardless of education level, the results of the second study suggest rather that poor
attitudes toward vaccination among non-Hispanic whites are burgeoning, and is stronger
than the wariness previously described in Hispanics.85 For example, in 1995, measles,
mumps, and rubella (MMR) vaccination coverage was 2.8% lower among Hispanic
children than non-Hispanic white children.86 MMR coverage increased from 87.9% in
1995 to 92.4% in 2011 for Hispanic children, and became significantly higher than for
non-Hispanic white children in 2010. According to assessments of medical records,
however, Hispanics had a 4-fold greater odds of over-reporting vaccination receipt than
non-Hispanic whites.87
While many HPV-related interventions have been designed and evaluated with
MSM populations, there were no interventions which targeted WSW, and none which
included heterosexual counterparts. The third study in this dissertation aimed to evaluate
how intervention effects differed between MSM and WSW and compared with
heterosexual men and women. There were significant differences between MSM and HSI
in effects on knowledge and attitude, with gay men reporting stronger baseline
knowledge and attitudes toward HPV, and retaining an advantage even after the
intervention experience. Among women, those who identified as bisexual demonstrated
higher knowledge scores than lesbian women at baseline, and had a significantly larger
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change in attitudes following the intervention experience. These contrasting findings
highlight the divergent HPV attitudes that women of different sexual orientations have,
and call attention to the perceived normative beliefs regarding STI susceptibility that
inform lesbian health propensities, and ultimately may be a barrier to HPV
vaccination.88,89
HPV educational efforts should place special emphasis on reaching heterosexual
men and lesbian women, who lag behind other sexual orientation subgroups in
knowledge and attitudes. There are no HPV interventions which are tailored for HSI men
and lesbian women, which reflect national priorities in cancer prevention. Many studies
cite provider recommendation barriers such as time constraints, low perceived threat to
the patient, and even preferential vaccination recommendations. 90 With the established
importance of receiving a provider recommendation for HPV vaccination, healthcare
providers may benefit from increased training on inclusive education of all vaccineeligible patients regardless of gender or orientation.
Strengths and Limitations
A limiting aspect of this study was the absence of a control or comparison group.
The rigor of the study could have been maximized by assigning half of the course
sections to the intervention as described, and the other half to a control arm receiving a
standard practices pamphlet or other written information. Alternately, participants could
have been randomly assigned to the intervention or control group following initial
recruitment.
For this intervention, a purposive sampling technique maximized
sociodemographic diversity among participants. While purposive sampling methods may
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be prone to researcher bias, the theoretical knowledge of the participants before the
project made researcher bias negligible. The women’s studies course from which
participants were recruited is historically known to have overrepresentation of LGBTQ
individuals. Likewise, the university offering this course is known to have a Hispanic
majority, being a Hispanic-Serving Institution. The actual class size and ratios of gender,
ethnicity, or sexual orientation groups were unknown and beyond control in the
participant recruitment process.
The pre-/post-test design, especially in the context of a brief intervention, was a
limitation and also a strength. Because the intervention did not extend beyond the
confines of a single class period, we were unable to measure long-term outcomes, such as
participant initiation or completion of the HPV vaccine series, or sustained knowledge
and/or attitude improvements over time. Usually, this design also prevents researchers
from establishing causality in the relationship between the intervention and outcome
measures. However, due to the brevity of our design, we can be almost certain that the
estimated effect can be attributed solely to our intervention.
The study also depended on self-reported data from participants, which increases
the likelihood that responses were subject to social desirability bias and recall bias. Since
the HPV vaccine is at least a two-dose series over a six-month period, the chance of
uncertainty among participants regarding number of doses received may be higher than if
a single-time event were assessed, such as the flu vaccine. However, a study of selfreported vaccine data compared to medical records found that HPV vaccine recall was
over 90% accurate.87
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Despite these limitations, the study had many strengths. The intervention proved
to be an excellent method for quickly improving knowledge and changing attitudes about
HPV and HPV vaccination among diverse college students. The measures used to
evaluate knowledge and attitudes demonstrated strong internal consistency.
The participants received the intervention well, which was evident in the
engagement of the students while the material was being delivered. Intervention
acceptability was confirmed in the post-test evaluation of the intervention components,
which all received positive scores ranging from 93-97% among participants. The
intervention itself was inexpensive and easy to implement, making potential widespread
use and adaptation feasible.
Recommendations
Lack of knowledge and poor attitudes regarding HPV and HPV vaccination
among sexually and ethnically diverse college students are inhibiting HPV vaccine
uptake in the United States. Heterosexual men, especially Hispanic heterosexual men,
and lesbian women face substantial barriers in learning about HPV. Inclusive,
comprehensive, judgement-free education, and the development of tailored and targeted
intervention for those less likely to receive information from usual pathways can help
improve vaccination rates in diverse populations of young adults. The combined effect of
comprehensive education and purposeful intervention would be instrumental in
addressing undervaccination, achieving acceptable vaccination rates, and controlling a
highly preventable virus.
Qualitative research can be conducted with target groups, such as Hispanic men
and lesbian women, to inform the design and development of interventions. HPV
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education messages should be tailored for these specific groups, and should incorporate
qualitative results to determine strategic and informed options for education providers,
locations, and approaches for intervention delivery. HPV interventions focused on
Hispanic men should take into account the role of gender in Hispanic culture, and its
intersection with class, nationality, sexual orientation, and religion to form the construct
of “machismo.” 65 Constructs such as “machismo” in Hispanic men frame key health
beliefs in Hispanic men and should be explored in future studies as a barrier to health
seeking behavior, such as HPV vaccination.91,92
As the intervention was implemented as a group with a purposive sample, the next
step would be to implement the intervention as a randomized controlled trial with larger
samples and in various settings. While the intervention was acceptable and efficacious in
the classroom setting, future implementers should be prepared for additional or different
barriers when studying diverse populations outside of this setting. Intervention
investigators are more frequently utilizing online or mobile platforms for intervention
delivery, which offer potential for impactful behavior change.93 While online
interventions are cheap, innovative, easy to populate, and have the benefit of evolving
with ongoing technological advances, they present new and unique challenges. Online or
mobile interventions are more prone to high attrition rates than face-to-face interventions
if the incentive is negligible. It is also difficult to assess the reach of the intervention, and
effect sizes are often small or insignificant.94
Future intervention research should consider incorporation of a third measurement
point at a later date to assess long-term knowledge and attitude outcomes, and to
determine if the intervention serves as a cue to action for HPV vaccination. The addition
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of another measurement point would also be useful in assessing the strength of behavioral
intention to vaccinate at baseline.
Vaccine hesitant attitudes may be a dimension to consider in the endeavor to
increase HPV vaccination, and is more difficult to diminish compared to lack of
awareness or knowledge, which is relatively easy to remedy. Evidence has shown when
vaccine hesitant parents were presented with risk-benefit information, their hesitant
attitudes were strengthened instead of lessened.95 Participants of that study tended to
focus on the segments of information which supported their hesitant views, while
rejecting the information that supported vaccination. While the current intervention
asserted only the safety and efficacy of the HPV vaccine, 10% participants holding
hesitant vaccine attitudes were less likely to accept the information. These participants
displayed attitude polarization that depended less on the intervention’s accuracy and
more on whether the information supported their position.96 Future research can include
increased measures of pre-existing vaccine attitudes to assess how hesitant attitudes can
be deterred. HPV and other vaccine interventions should include educational materials
designed to dispel vaccine myths and reduce judgement errors while concurrently
promoting the vaccine.
Finally, special consideration should be given to healthcare providers at all levels
of the provider spectrum. Evidence points to provider recommendation as the single
strongest event in the behavioral path to vaccination, with adolescents who received a
recommendation five times more likely to receive a vaccination.97 Despite this, providers
often do not suggest HPV vaccination with other routine adolescent vaccines, and are less
likely to provide recommendations to racial/ethnic minorities. Future studies should
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assess attitude and prejudicial predictors of HPV vaccination recommendations among
healthcare providers. Medical education programs should also develop HPV and HPV
vaccination educational modules to increase provider confidence in giving strong
vaccination recommendations, especially in response to hesitant attitudes. As financial
barriers to vaccination decrease due to policy and NGO efforts, 90 attention should be
turned to address non-financial barriers, such as lack of HPV knowledge, hesitant vaccine
attitudes, and weak or optional provider recommendations.
Conclusions
No one intervention is efficacious enough to close all the gaps in HPV
knowledge, attitudes, beliefs, and practices.84 Each intervention assesses and addresses
different dimensions of awareness, knowledge, attitude, and behavior, and do so within
the confines of specific populations. In this sense, the individual interventions are limited,
but if strategically and synergistically placed, together can create a large impact. Public
health professionals in education, academic, governmental and non-governmental sectors
may increase multidisciplinary, collaborative efforts to achieve such impact. Further
intervention is necessary for certain populations and at all ecological levels- individual,
community, and policy- to alleviate the burden of HPV infection and reduce HPV-related
cancers.
A brief, educational intervention designed to improve HPV-related awareness,
knowledge, and attitudes can be efficacious in changing attitudes and increasing
knowledge among college students. Tailored and targeted HPV intervention is acceptable
to sexually and ethnically diverse college students in south Florida, and may contribute to
local and national goals to reduce HPV-related clinical outcomes.
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Appendix B
Questionnaire

The EquiVax Project
Thank you for agreeing to participate in our study. It explores issues
MM/YYYY
related to human papillomavirus (HPV).
The survey is anonymous, and will take about 5 minutes to complete. If you’re unsure of what the correct
answer is, please give us your best answer.

First, a few questions about you. Please respond to each of the following:
1.

What is the month and year of your birth? ________________

2.

What is your gender? (Please circle one)
(1) Male (2) Female (3) Transgender M to F (4) Transgender F to M (5) Other: __________

3.

Ethnicity (please circle one):
(1) Not Hispanic or Latino

4.

(2) Hispanic or Latino (3) Not sure or unknown

Race (please circle all that apply):
(1) American Indian or Alaska Native (2) Asian/Pacific Islander

(3) Black/African American

(4) White/Caucasian (5) Not sure or unknown (8) Other: ___________________________
5.

Do you currently have any form of health insurance coverage?
(1) Yes

6.

(2) No

(3) Don’t Know

Current relationship status (please circle one):
(1) Single (2) Married

7.

(3) Divorced/Widowed

(4) In a Relationship (5) Other: _________

Your sexual orientation (please circle one):
(1) Heterosexual/straight

(2) Gay/Lesbian

(3) Bisexual

(4) Not sure

8.

Have you ever had: (circle yes or no for each)

9.

a.) Vaginal (penetrative) sex?
(1) Yes (2) No
b.) Oral sex?
(1) Yes (2) No
c.) Anal sex?
(1) Yes (2) No
How many different sex partners have you had in your lifetime

(5) Other: ________

(please circle one)?
[0]

[1]

[2-5]

[6-10]

[11-15]

[>15]

10. Have you heard of HPV or human papillomavirus before today
(please circle one)?
(1) Yes

(2) No

(3) Don’t Know

11. How many doses of HPV vaccine have you received as of today
(please circle one)?
[0]

[1]

[2]

[3]

[Don’t know]

12. If not already fully vaccinated against HPV, are you willing to take the HPV vaccine?
(1) Yes

(2) No

(3) Don’t Know

Circle the number that best describes your knowledge
or perception at this time.

Nothing at all

A
little

A
moderate
amount

Quite a
lot

13. How much would you say you know about
HPV or human papillomavirus?

1

2

3

4

14. How much would you say you know about
HPV vaccine?

1

2

3

4

Strongly
Agree

Agre
e

Neutr
al

Disagree

Stron
gly
Disag
ree

Don’t
Know

15. HPV infection is rare

1

2

3

4

5

6

16. Only people who have sex with lots of
other people get HPV

1

2

3

4

5

6

17. HPV is a serious health concern for
women

1

2

3

4

5

6

18. HPV is a serious health concern for men

1

2

3

4

5

6

19. HPV infection is a serious threat to my
own health

1

2

3

4

5

6

20. I would be willing to use an anal swab
on myself to screen for anal cancer

1

2

3

4

5

6

21. Vaccines in general are safe and
effective

1

2

3

4

5

6

22. Women should be vaccinated against
HPV

1

2

3

4

5

6

23. Men should be vaccinated against HPV

1

2

3

4

5

6

24. Everyone should be vaccinated against
HPV

1

2

3

4

5

6

25. My opinion of the HPV vaccine is
mostly positive

1

2

3

4

5

6

Please provide responses for each statement
below. Circle the number that best describes
your agreement with each statement at this
time.
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Please answer the following questions by circling True or False:
26. The HPV virus causes herpes in men and women

TRUE

FALSE

Don’t know

27. HPV infection can cause genital warts

TRUE

FALSE

Don’t know

28. You can only get HPV from having sex

TRUE

FALSE

Don’t know

29. Acquired Immune Deficiency Syndrome (AIDS) is
caused by human papillomavirus

TRUE

FALSE

Don’t know

30. The only way you can protect yourself from HPV is to
use a condom

TRUE

FALSE

Don’t know

31. Some strains of HPV are harmless

TRUE

FALSE

Don’t know

32. HPV infection can cause cancer

TRUE

FALSE

Don’t know

33. Before today, I never thought about asking about the
HPV vaccine for myself

TRUE

FALSE

Don’t know

34. Student Health Services offers HPV vaccine

TRUE

FALSE

Don’t know

Please evaluate the presentation

1. What did you think about the PowerPoint presentation (please circle one)?
(1) Too long

(2) Too short

(3) Just about right (4) Other: ___________________________

2. How much information had you received about HPV before the presentation
(please circle one)?
(1) None (2) Very Little (3) Some (4) Quite a bit (5) A great amount

3. How useful was the question and answer session that followed the
presentation (please circle one)?
(1) Very useful

(2) somewhat useful (3) not very useful

(4) Not at all useful

4. Please rate your overall assessment of today’s HPV educational experience
(please circle one)?
(1) Very positive (2) Positive (3) Neutral (4) Negative

(5) Very Negative

5. How much did you learn from your participation (please circle one)?
(1) Nothing

(2) Very Little (3) Some things

amount
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(4) Quite a bit (5) A great

B. Now about HPV. Circle the number that best describes your knowledge or perception at this time.
Extremely
Knowledgeable

Somewhat
Knowledgeable

Very Little
Knowledge

No
Knowledge

6. How much would you say
you know about HPV or
human papillomavirus?

1

2

3

4

7. How much would you say
you know about the HPV
vaccine?

1

2

3

4

Strongly
Agree

Agree

Neutral

Disagree

Strongl
y
Disagre
e

Don’t
Know

8. HPV infection is rare

1

2

3

4

5

6

9. Only people who have sex with
lots of other people get HPV

1

2

3

4

5

6

10. HPV is a serious concern for
women

1

2

3

4

5

6

Neutral

Disagree

Strongl
y
Disagre
e

Don’t
Know

Please provide responses for each
statement below. Circle the number
that best describes your knowledge or
feelings at this time.

Please provide responses for each
statement below. Circle the number
that best describes your knowledge or
feelings at this time.

Strongly
Agree

Agree

11. HPV is a serious concern for men

1

2

3

4

5

6

12. HPV infection is a serious threat
to my own health

1

2

3

4

5

6

13. I would be willing to use an anal
swab on myself to screen for anal
cancer

1

2

3

4

5

6

14. Vaccines in general are safe and
effective

1

2

3

4

5

6

15. Women should be vaccinated
against HPV

1

2

3

4

5

6
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16. Men should be vaccinated against
HPV

1

2

3

4

5

6

17. Everyone should be vaccinated
against HPV

1

2

3

4

5

6

18. My opinion of the HPV vaccine is
mostly positive

1

2

3

4

5

6

Please answer the following questions by circling True or False regarding HPV:
19. The HPV virus causes herpes in men and women

TRUE

FALSE

20. HPV infection can cause genital warts

TRUE

FALSE

21. You can only get HPV from having sex

TRUE

FALSE

22. Acquired Immune Deficiency Syndrome (AIDS) is caused by human
papillomavirus

TRUE

FALSE

23. The only way you can protect yourself from HPV is to use a condom

TRUE

FALSE

24. Some strains of HPV are harmless

TRUE

FALSE

25. HPV infection can cause cancer

TRUE

FALSE

26. Before today, I never thought about asking about the HPV vaccine for
myself

TRUE

FALSE

27. Student Health Services offers HPV vaccine

TRUE

FALSE

Major: _____________________________________
Thank you!
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